{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:45:14Z","timestamp":1792899914598,"version":"4.5.0"},"reference-count":327,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institute of Health","award":["R01 HL148190"],"award-info":[{"award-number":["R01 HL148190"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10286-023-00948-8","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:01:57Z","timestamp":1683810117000},"page":"491-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Autonomic control of ventricular function in health and disease: current state of the art"],"prefix":"10.1007","volume":"33","author":[{"given":"Valerie Y. H.","family":"van Weperen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal M.","family":"Ripplinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-9706","authenticated-orcid":false,"given":"Marmar","family":"Vaseghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/cphy.c150046","volume":"6","author":"JL Ardell","year":"2016","unstructured":"Ardell JL, Armour JA (2016) Neurocardiology: structure-based function. Compr Physiol 6:1635\u20131653. https:\/\/doi.org\/10.1002\/cphy.c150046","journal-title":"Compr Physiol"},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"R262","DOI":"10.1152\/ajpregu.00183.2004","volume":"287","author":"JA Armour","year":"2004","unstructured":"Armour JA (2004) Cardiac neuronal hierarchy in health and disease. Am J Physiol Regul Integr Comp Physiol 287:R262-271. https:\/\/doi.org\/10.1152\/ajpregu.00183.2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/cvr\/28.8.1218","volume":"28","author":"JA Armour","year":"1994","unstructured":"Armour JA, Huang MH, Pelleg A, Sylven C (1994) Responsiveness of in situ canine nodose ganglion afferent neurones to epicardial mechanical or chemical stimuli. Cardiovasc Res 28:1218\u20131225. https:\/\/doi.org\/10.1093\/cvr\/28.8.1218","journal-title":"Cardiovasc Res"},{"key":"948_CR4","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1172\/JCI86812","volume":"127","author":"X Du","year":"2017","unstructured":"Du X, Hao H, Yang Y, Huang S, Wang C, Gigout S, Ramli R, Li X, Jaworska E, Edwards I, Deuchars J, Yanagawa Y, Qi J, Guan B, Jaffe DB, Zhang H, Gamper N (2017) Local GABAergic signaling within sensory ganglia controls peripheral nociceptive transmission. J Clin Invest 127:1741\u20131756. https:\/\/doi.org\/10.1172\/JCI86812","journal-title":"J Clin Invest"},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.01.022","volume":"160","author":"C Hanack","year":"2015","unstructured":"Hanack C, Moroni M, Lima WC, Wende H, Kirchner M, Adelfinger L, Schrenk-Siemens K, Tappe-Theodor A, Wetzel C, Kuich PH, Gassmann M, Roggenkamp D, Bettler B, Lewin GR, Selbach M, Siemens J (2015) GABA blocks pathological but not acute TRPV1 pain signals. Cell 160:759\u2013770. https:\/\/doi.org\/10.1016\/j.cell.2015.01.022","journal-title":"Cell"},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"13425","DOI":"10.1523\/JNEUROSCI.0454-13.2013","volume":"33","author":"P Pagadala","year":"2013","unstructured":"Pagadala P, Park CK, Bang S, Xu ZZ, Xie RG, Liu T, Han BX, Tracey WD Jr, Wang F, Ji RR (2013) Loss of NR1 subunit of NMDARs in primary sensory neurons leads to hyperexcitability and pain hypersensitivity: involvement of Ca(2+)-activated small conductance potassium channels. J Neurosci 33:13425\u201313430. https:\/\/doi.org\/10.1523\/JNEUROSCI.0454-13.2013","journal-title":"J Neurosci"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neuroscience.2012.06.025","volume":"220","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Lu SG, Gold MS (2012) Persistent inflammation increases GABA-induced depolarization of rat cutaneous dorsal root ganglion neurons in vitro. Neuroscience 220:330\u2013340. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.06.025","journal-title":"Neuroscience"},{"key":"948_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511541667","volume-title":"Integrative action of the autonomic nervous system: neurobiology of homeostasis","author":"W Janig","year":"2006","unstructured":"Janig W (2006) Integrative action of the autonomic nervous system: neurobiology of homeostasis. Cambridge University Press, Cambridge"},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"e155747","DOI":"10.1172\/jci.insight.155747","volume":"7","author":"S Salavatian","year":"2022","unstructured":"Salavatian S, Hoang JD, Yamaguchi N, Lokhandwala ZA, Swid MA, Armour JA, Ardell JL, Vaseghi M (2022) Myocardial infarction reduces cardiac nociceptive neurotransmission through the vagal ganglia. JCI Insight 7:e155747. https:\/\/doi.org\/10.1172\/jci.insight.155747","journal-title":"JCI Insight"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-1838(89)90170-7","volume":"26","author":"DA Hopkins","year":"1989","unstructured":"Hopkins DA, Armour JA (1989) Ganglionic distribution of afferent neurons innervating the canine heart and cardiopulmonary nerves. J Auton Nerv Syst 26:213\u2013222. https:\/\/doi.org\/10.1016\/0165-1838(89)90170-7","journal-title":"J Auton Nerv Syst"},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/hy0102.099200","volume":"39","author":"A Malliani","year":"2002","unstructured":"Malliani A, Montano N (2002) Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39:63\u201368. https:\/\/doi.org\/10.1161\/hy0102.099200","journal-title":"Hypertension"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1113\/JP273764","volume":"595","author":"HJ Wang","year":"2017","unstructured":"Wang HJ, Rozanski GJ, Zucker IH (2017) Cardiac sympathetic afferent reflex control of cardiac function in normal and chronic heart failure states. J Physiol 595:2519\u20132534. https:\/\/doi.org\/10.1113\/JP273764","journal-title":"J Physiol"},{"key":"948_CR13","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195141290.001.0001","volume-title":"Basic and clinical neurocardiology","author":"JA Armour","year":"2004","unstructured":"Armour JA, Ardell JL (2004) Basic and clinical neurocardiology. Oxford University Press, New York"},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10641969509087050","volume":"17","author":"MW Chapleau","year":"1995","unstructured":"Chapleau MW, Hajduczok G, Sharma RV, Wachtel RE, Cunningham JT, Sullivan MJ, Abboud FM (1995) Mechanisms of baroreceptor activation. Clin Exp Hypertens 17:1\u201313. https:\/\/doi.org\/10.3109\/10641969509087050","journal-title":"Clin Exp Hypertens"},{"key":"948_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1152\/physrev.1976.56.1.100","volume":"56","author":"HR Kirchheim","year":"1976","unstructured":"Kirchheim HR (1976) Systemic arterial baroreceptor reflexes. Physiol Rev 56:100\u2013177. https:\/\/doi.org\/10.1152\/physrev.1976.56.1.100","journal-title":"Physiol Rev"},{"key":"948_CR16","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/cphy.c140004","volume":"4","author":"PG Guyenet","year":"2014","unstructured":"Guyenet PG (2014) Regulation of breathing and autonomic outflows by chemoreceptors. Compr Physiol 4:1511\u20131562. https:\/\/doi.org\/10.1002\/cphy.c140004","journal-title":"Compr Physiol"},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cphy.c100069","volume":"2","author":"P Kumar","year":"2012","unstructured":"Kumar P, Prabhakar NR (2012) Peripheral chemoreceptors: function and plasticity of the carotid body. Compr Physiol 2:141\u2013219. https:\/\/doi.org\/10.1002\/cphy.c100069","journal-title":"Compr Physiol"},{"key":"948_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-18440-1_19","volume":"860","author":"HD Schultz","year":"2015","unstructured":"Schultz HD, Marcus NJ, Del Rio R (2015) Role of the carotid body chemoreflex in the pathophysiology of heart failure: a perspective from animal studies. Adv Exp Med Biol 860:167\u2013185. https:\/\/doi.org\/10.1007\/978-3-319-18440-1_19","journal-title":"Adv Exp Med Biol"},{"key":"948_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/01.res.64.3.554","volume":"64","author":"ZJ Bosnjak","year":"1989","unstructured":"Bosnjak ZJ, Kampine JP (1989) Cardiac sympathetic afferent cell bodies are located in the peripheral nervous system of the cat. Circ Res 64:554\u2013562. https:\/\/doi.org\/10.1161\/01.res.64.3.554","journal-title":"Circ Res"},{"key":"948_CR20","first-page":"103","volume":"5","author":"MA Kirchberber","year":"1975","unstructured":"Kirchberber MA, Tada M, Katz AM (1975) Phospholamban: a regulatory protein of the cardiac sarcoplasmic reticulum. Recent Adv Stud Cardiac Struct Metab 5:103\u2013115","journal-title":"Recent Adv Stud Cardiac Struct Metab"},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/415219a","volume":"415","author":"S Nattel","year":"2002","unstructured":"Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415:219\u2013226. https:\/\/doi.org\/10.1038\/415219a","journal-title":"Nature"},{"key":"948_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0006-3495(00)76596-9","volume":"78","author":"TR Shannon","year":"2000","unstructured":"Shannon TR, Ginsburg KS, Bers DM (2000) Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J 78:334\u2013343. https:\/\/doi.org\/10.1016\/S0006-3495(00)76596-9","journal-title":"Biophys J"},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1469-7793.2001.t01-1-00837.x","volume":"533","author":"S Viatchenko-Karpinski","year":"2001","unstructured":"Viatchenko-Karpinski S, Gyorke S (2001) Modulation of the Ca(2+)-induced Ca(2+) release cascade by beta-adrenergic stimulation in rat ventricular myocytes. J Physiol 533:837\u2013848. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.t01-1-00837.x","journal-title":"J Physiol"},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yjmcc.2007.04.017","volume":"43","author":"A Bucchi","year":"2007","unstructured":"Bucchi A, Baruscotti M, Robinson RB, DiFrancesco D (2007) Modulation of rate by autonomic agonists in SAN cells involves changes in diastolic depolarization and the pacemaker current. J Mol Cell Cardiol 43:39\u201348. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.04.017","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/01.RES.0000247933.66532.0b","volume":"99","author":"KY Bogdanov","year":"2006","unstructured":"Bogdanov KY, Maltsev VA, Vinogradova TM, Lyashkov AE, Spurgeon HA, Stern MD, Lakatta EG (2006) Membrane potential fluctuations resulting from submembrane Ca2+ releases in rabbit sinoatrial nodal cells impart an exponential phase to the late diastolic depolarization that controls their chronotropic state. Circ Res 99:979\u2013987. https:\/\/doi.org\/10.1161\/01.RES.0000247933.66532.0b","journal-title":"Circ Res"},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/CIRCRESAHA.109.206078","volume":"106","author":"EG Lakatta","year":"2010","unstructured":"Lakatta EG, Maltsev VA, Vinogradova TM (2010) A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart\u2019s pacemaker. Circ Res 106:659\u2013673. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.206078","journal-title":"Circ Res"},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/01.RES.0000204575.94040.d1","volume":"98","author":"TM Vinogradova","year":"2006","unstructured":"Vinogradova TM, Lyashkov AE, Zhu W, Ruknudin AM, Sirenko S, Yang D, Deo S, Barlow M, Johnson S, Caffrey JL, Zhou YY, Xiao RP, Cheng H, Stern MD, Maltsev VA, Lakatta EG (2006) High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ Res 98:505\u2013514. https:\/\/doi.org\/10.1161\/01.RES.0000204575.94040.d1","journal-title":"Circ Res"},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"H769","DOI":"10.1152\/ajpheart.2000.278.3.H769","volume":"278","author":"L Li","year":"2000","unstructured":"Li L, Desantiago J, Chu G, Kranias EG, Bers DM (2000) Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol 278:H769-779. https:\/\/doi.org\/10.1152\/ajpheart.2000.278.3.H769","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/hh1001.091640","volume":"88","author":"JC Kentish","year":"2001","unstructured":"Kentish JC, McCloskey DT, Layland J, Palmer S, Leiden JM, Martin AF, Solaro RJ (2001) Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res 88:1059\u20131065. https:\/\/doi.org\/10.1161\/hh1001.091640","journal-title":"Circ Res"},{"key":"948_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1126\/science.1066843","volume":"295","author":"SO Marx","year":"2002","unstructured":"Marx SO, Kurokawa J, Reiken S, Motoike H, D\u2019Armiento J, Marks AR, Kass RS (2002) Requirement of a macromolecular signaling complex for beta-adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295:496\u2013499. https:\/\/doi.org\/10.1126\/science.1066843","journal-title":"Science"},{"key":"948_CR31","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1113\/JP272883","volume":"595","author":"N Chiamvimonvat","year":"2017","unstructured":"Chiamvimonvat N, Chen-Izu Y, Clancy CE, Deschenes I, Dobrev D, Heijman J, Izu L, Qu Z, Ripplinger CM, Vandenberg JI, Weiss JN, Koren G, Banyasz T, Grandi E, Sanguinetti MC, Bers DM, Nerbonne JM (2017) Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics. J Physiol 595:2229\u20132252. https:\/\/doi.org\/10.1113\/JP272883","journal-title":"J Physiol"},{"key":"948_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.pharmtox.052808.102215","volume":"49","author":"G Burnstock","year":"2009","unstructured":"Burnstock G (2009) Autonomic neurotransmission: 60 years since sir Henry Dale. Annu Rev Pharmacol Toxicol 49:1\u201330. https:\/\/doi.org\/10.1146\/annurev.pharmtox.052808.102215","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"948_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.yjmcc.2011.11.016","volume":"52","author":"N Herring","year":"2012","unstructured":"Herring N, Cranley J, Lokale MN, Li D, Shanks J, Alston EN, Girard BM, Carter E, Parsons RL, Habecker BA, Paterson DJ (2012) The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. J Mol Cell Cardiol 52:667\u2013676. https:\/\/doi.org\/10.1016\/j.yjmcc.2011.11.016","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.yjmcc.2004.11.001","volume":"38","author":"P Heredia Mdel","year":"2005","unstructured":"Heredia Mdel P, Delgado C, Pereira L, Perrier R, Richard S, Vassort G, Benitah JP, Gomez AM (2005) Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation. J Mol Cell Cardiol 38:205\u2013212. https:\/\/doi.org\/10.1016\/j.yjmcc.2004.11.001","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR35","doi-asserted-by":"publisher","first-page":"e135519","DOI":"10.1172\/jci.insight.135519","volume":"5","author":"JD Hoang","year":"2020","unstructured":"Hoang JD, Salavatian S, Yamaguchi N, Swid MA, David H, Vaseghi M (2020) Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y. JCI Insight 5:e135519. https:\/\/doi.org\/10.1172\/jci.insight.135519","journal-title":"JCI Insight"},{"key":"948_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.yjmcc.2007.10.001","volume":"44","author":"N Herring","year":"2008","unstructured":"Herring N, Lokale MN, Danson EJ, Heaton DA, Paterson DJ (2008) Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. J Mol Cell Cardiol 44:477\u2013485. https:\/\/doi.org\/10.1016\/j.yjmcc.2007.10.001","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.res.68.5.1204","volume":"68","author":"T Opthof","year":"1991","unstructured":"Opthof T, Misier AR, Coronel R, Vermeulen JT, Verberne HJ, Frank RG, Moulijn AC, van Capelle FJ, Janse MJ (1991) Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res 68:1204\u20131215. https:\/\/doi.org\/10.1161\/01.res.68.5.1204","journal-title":"Circ Res"},{"key":"948_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/01.res.18.4.416","volume":"18","author":"F Yanowitz","year":"1966","unstructured":"Yanowitz F, Preston JB, Abildskov JA (1966) Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ Res 18:416\u2013428. https:\/\/doi.org\/10.1161\/01.res.18.4.416","journal-title":"Circ Res"},{"key":"948_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0002-8703(85)90414-4","volume":"109","author":"J Cinca","year":"1985","unstructured":"Cinca J, Evangelista A, Montoyo J, Barutell C, Figueras J, Valle V, Rius J, Soler-Soler J (1985) Electrophysiologic effects of unilateral right and left stellate ganglion block on the human heart. Am Heart J 109:46\u201354. https:\/\/doi.org\/10.1016\/0002-8703(85)90414-4","journal-title":"Am Heart J"},{"key":"948_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00000542-197802000-00009","volume":"48","author":"MC Rogers","year":"1978","unstructured":"Rogers MC, Battit G, McPeek B, Todd D (1978) Lateralization of sympathetic control of the human sinus node: ECG changes of stellate ganglion block. Anesthesiology 48:139\u2013141. https:\/\/doi.org\/10.1097\/00000542-197802000-00009","journal-title":"Anesthesiology"},{"key":"948_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1399-6576.1996.tb04430.x","volume":"40","author":"W Schlack","year":"1996","unstructured":"Schlack W, Thamer V (1996) Unilateral changes of sympathetic tone to the heart impair left ventricular function. Acta Anaesthesiol Scand 40:262\u2013271. https:\/\/doi.org\/10.1111\/j.1399-6576.1996.tb04430.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"948_CR42","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.hrthm.2012.03.052","volume":"9","author":"M Vaseghi","year":"2012","unstructured":"Vaseghi M, Zhou W, Shi J, Ajijola OA, Hadaya J, Shivkumar K, Mahajan A (2012) Sympathetic innervation of the anterior left ventricular wall by the right and left stellate ganglia. Heart Rhythm 9:1303\u20131309. https:\/\/doi.org\/10.1016\/j.hrthm.2012.03.052","journal-title":"Heart Rhythm"},{"key":"948_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1113\/expphysiol.2007.041178","volume":"93","author":"JA Armour","year":"2008","unstructured":"Armour JA (2008) Potential clinical relevance of the \u2018little brain\u2019 on the mammalian heart. Exp Physiol 93:165\u2013176. https:\/\/doi.org\/10.1113\/expphysiol.2007.041178","journal-title":"Exp Physiol"},{"key":"948_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1113\/jphysiol.1957.sp005703","volume":"135","author":"E Agostoni","year":"1957","unstructured":"Agostoni E, Chinnock JE, De Daly MB, Murray JG (1957) Functional and histological studies of the vagus nerve and its branches to the heart, lungs and abdominal viscera in the cat. J Physiol 135:182\u2013205. https:\/\/doi.org\/10.1113\/jphysiol.1957.sp005703","journal-title":"J Physiol"},{"key":"948_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s003950170003","volume":"96","author":"OE Brodde","year":"2001","unstructured":"Brodde OE, Bruck H, Leineweber K, Seyfarth T (2001) Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528\u2013538. https:\/\/doi.org\/10.1007\/s003950170003","journal-title":"Basic Res Cardiol"},{"key":"948_CR46","doi-asserted-by":"publisher","first-page":"H722","DOI":"10.1152\/ajpheart.00279.2014","volume":"307","author":"K Yamakawa","year":"2014","unstructured":"Yamakawa K, So EL, Rajendran PS, Hoang JD, Makkar N, Mahajan A, Shivkumar K, Vaseghi M (2014) Electrophysiological effects of right and left vagal nerve stimulation on the ventricular myocardium. Am J Physiol Heart Circ Physiol 307:H722-731. https:\/\/doi.org\/10.1152\/ajpheart.00279.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.autneu.2015.10.002","volume":"193","author":"SY Han","year":"2015","unstructured":"Han SY, Bolter CP (2015) Effects of tertiapin-Q and ZD7288 on changes in sinoatrial pacemaker rhythm during vagal stimulation. Auton Neurosci 193:117\u2013126. https:\/\/doi.org\/10.1016\/j.autneu.2015.10.002","journal-title":"Auton Neurosci"},{"key":"948_CR48","doi-asserted-by":"publisher","first-page":"29059","DOI":"10.1074\/jbc.270.49.29059","volume":"270","author":"G Krapivinsky","year":"1995","unstructured":"Krapivinsky G, Krapivinsky L, Wickman K, Clapham DE (1995) G beta gamma binds directly to the G protein-gated K+ channel, IKACh. J Biol Chem 270:29059\u201329062. https:\/\/doi.org\/10.1074\/jbc.270.49.29059","journal-title":"J Biol Chem"},{"key":"948_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0165-1838(91)90117-l","volume":"32","author":"N Manabe","year":"1991","unstructured":"Manabe N, Foldes FF, Torocsik A, Nagashima H, Goldiner PL, Vizi ES (1991) Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst 32:233\u2013242. https:\/\/doi.org\/10.1016\/0165-1838(91)90117-l","journal-title":"J Auton Nerv Syst"},{"key":"948_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01417206","volume":"265","author":"K Loffelholz","year":"1969","unstructured":"Loffelholz K, Muscholl E (1969) A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmakol 265:1\u201315. https:\/\/doi.org\/10.1007\/BF01417206","journal-title":"Naunyn Schmiedebergs Arch Pharmakol"},{"key":"948_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1113\/jphysiol.2002.033100","volume":"548","author":"H Ishibashi","year":"2003","unstructured":"Ishibashi H, Umezu M, Jang IS, Ito Y, Akaike N (2003) Alpha 1-adrenoceptor-activated cation currents in neurones acutely isolated from rat cardiac parasympathetic ganglia. J Physiol 548:111\u2013120. https:\/\/doi.org\/10.1113\/jphysiol.2002.033100","journal-title":"J Physiol"},{"key":"948_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0196-9781(84)90232-8","volume":"5","author":"J Christophe","year":"1984","unstructured":"Christophe J, Waelbroeck M, Chatelain P, Robberecht P (1984) Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides 5:341\u2013353. https:\/\/doi.org\/10.1016\/0196-9781(84)90232-8","journal-title":"Peptides"},{"key":"948_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0167-0115(84)90065-x","volume":"8","author":"P De Neef","year":"1984","unstructured":"De Neef P, Robberecht P, Chatelain P, Waelbroeck M, Christophe J (1984) The in\u00a0vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart. Regul Pept 8:237\u2013244. https:\/\/doi.org\/10.1016\/0167-0115(84)90065-x","journal-title":"Regul Pept"},{"key":"948_CR54","doi-asserted-by":"publisher","first-page":"H311","DOI":"10.1152\/ajpheart.1988.255.2.H311","volume":"255","author":"DF Rigel","year":"1988","unstructured":"Rigel DF (1988) Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. Am J Physiol 255:H311-317. https:\/\/doi.org\/10.1152\/ajpheart.1988.255.2.H311","journal-title":"Am J Physiol"},{"key":"948_CR55","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1113\/expphysiol.2006.033605","volume":"91","author":"K Hogan","year":"2006","unstructured":"Hogan K, Markos F (2006) Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in\u00a0vitro. Exp Physiol 91:641\u2013646. https:\/\/doi.org\/10.1113\/expphysiol.2006.033605","journal-title":"Exp Physiol"},{"key":"948_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pharmthera.2004.11.003","volume":"106","author":"EJ Danson","year":"2005","unstructured":"Danson EJ, Choate JK, Paterson DJ (2005) Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol Ther 106:57\u201374. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.11.003","journal-title":"Pharmacol Ther"},{"key":"948_CR57","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.1999.277.2.H812","volume":"277","author":"W Wang","year":"1999","unstructured":"Wang W, Schultz HD, Ma R (1999) Cardiac sympathetic afferent sensitivity is enhanced in heart failure. Am J Physiol 277:H812-817. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.2.H812","journal-title":"Am J Physiol"},{"key":"948_CR58","doi-asserted-by":"publisher","first-page":"H19","DOI":"10.1152\/ajpheart.1999.276.1.H19","volume":"276","author":"R Ma","year":"1999","unstructured":"Ma R, Zucker IH, Wang W (1999) Reduced NO enhances the central gain of cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol 276:H19-26. https:\/\/doi.org\/10.1152\/ajpheart.1999.276.1.H19","journal-title":"Am J Physiol"},{"key":"948_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0006-8993(96)00620-8","volume":"734","author":"KP Patel","year":"1996","unstructured":"Patel KP, Zhang K, Zucker IH, Krukoff TL (1996) Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure. Brain Res 734:109\u2013115. https:\/\/doi.org\/10.1016\/0006-8993(96)00620-8","journal-title":"Brain Res"},{"key":"948_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.autneu.2016.05.001","volume":"197","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Ajijola OA, Aliotta E, Armour JA, Ardell JL, Shivkumar K (2016) Pathological effects of chronic myocardial infarction on peripheral neurons mediating cardiac neurotransmission. Auton Neurosci 197:34\u201340. https:\/\/doi.org\/10.1016\/j.autneu.2016.05.001","journal-title":"Auton Neurosci"},{"key":"948_CR61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/HYPERTENSIONAHA.114.03699","volume":"64","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, Wang W, Cornish KG, Rozanski GJ, Zucker IH (2014) Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. Hypertension 64:745\u2013755. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03699","journal-title":"Hypertension"},{"key":"948_CR62","doi-asserted-by":"publisher","first-page":"e124477","DOI":"10.1172\/jci.insight.124477","volume":"5","author":"K Yoshie","year":"2020","unstructured":"Yoshie K, Rajendran PS, Massoud L, Mistry J, Swid MA, Wu X, Sallam T, Zhang R, Goldhaber JI, Salavatian S, Ajijola OA (2020) Cardiac TRPV1 afferent signaling promotes arrhythmogenic ventricular remodeling after myocardial infarction. JCI Insight 5:e124477. https:\/\/doi.org\/10.1172\/jci.insight.124477","journal-title":"JCI Insight"},{"key":"948_CR63","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1113\/JP271165","volume":"594","author":"PS Rajendran","year":"2016","unstructured":"Rajendran PS, Nakamura K, Ajijola OA, Vaseghi M, Armour JA, Ardell JL, Shivkumar K (2016) Myocardial infarction induces structural and functional remodelling of the intrinsic cardiac nervous system. J Physiol 594:321\u2013341. https:\/\/doi.org\/10.1113\/JP271165","journal-title":"J Physiol"},{"key":"948_CR64","doi-asserted-by":"publisher","first-page":"e94715","DOI":"10.1172\/jci.insight.94715","volume":"2","author":"OA Ajijola","year":"2017","unstructured":"Ajijola OA, Hoover DB, Simerly TM, Brown TC, Yanagawa J, Biniwale RM, Lee JM, Sadeghi A, Khanlou N, Ardell JL, Shivkumar K (2017) Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm. JCI Insight 2:e94715. https:\/\/doi.org\/10.1172\/jci.insight.94715","journal-title":"JCI Insight"},{"key":"948_CR65","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jacc.2011.11.030","volume":"59","author":"S Han","year":"2012","unstructured":"Han S, Kobayashi K, Joung B, Piccirillo G, Maruyama M, Vinters HV, March K, Lin SF, Shen C, Fishbein MC, Chen PS, Chen LS (2012) Electroanatomic remodeling of the left stellate ganglion after myocardial infarction. J Am Coll Cardiol 59:954\u2013961. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.030","journal-title":"J Am Coll Cardiol"},{"key":"948_CR66","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1113\/JP276962","volume":"598","author":"EN Bardsley","year":"2020","unstructured":"Bardsley EN, Paterson DJ (2020) Neurocardiac regulation: from cardiac mechanisms to novel therapeutic approaches. J Physiol 598:2957\u20132976. https:\/\/doi.org\/10.1113\/JP276962","journal-title":"J Physiol"},{"key":"948_CR67","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/HYPERTENSIONAHA.120.15922","volume":"76","author":"H Davis","year":"2020","unstructured":"Davis H, Herring N, Paterson DJ (2020) Downregulation of M current is coupled to membrane excitability in sympathetic neurons before the onset of hypertension. Hypertension 76:1915\u20131923. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15922","journal-title":"Hypertension"},{"key":"948_CR68","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.yjmcc.2006.05.007","volume":"41","author":"L Wang","year":"2006","unstructured":"Wang L, Li D, Plested CP, Dawson T, Teschemacher AG, Paterson DJ (2006) Noradrenergic neuron-specific overexpression of nNOS in cardiac sympathetic nerves decreases neurotransmission. J Mol Cell Cardiol 41:364\u2013370. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.05.007","journal-title":"J Mol Cell Cardiol"},{"key":"948_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.res.77.4.841","volume":"77","author":"P Schwarz","year":"1995","unstructured":"Schwarz P, Diem R, Dun NJ, Forstermann U (1995) Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 77:841\u2013848. https:\/\/doi.org\/10.1161\/01.res.77.4.841","journal-title":"Circ Res"},{"key":"948_CR70","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0008-6363(99)00163-7","volume":"43","author":"JL Balligand","year":"1999","unstructured":"Balligand JL (1999) Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res 43:607\u2013620. https:\/\/doi.org\/10.1016\/s0008-6363(99)00163-7","journal-title":"Cardiovasc Res"},{"key":"948_CR71","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1172\/JCI39778","volume":"120","author":"H Kanazawa","year":"2010","unstructured":"Kanazawa H, Ieda M, Kimura K, Arai T, Kawaguchi-Manabe H, Matsuhashi T, Endo J, Sano M, Kawakami T, Kimura T, Monkawa T, Hayashi M, Iwanami A, Okano H, Okada Y, Ishibashi-Ueda H, Ogawa S, Fukuda K (2010) Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest 120:408\u2013421. https:\/\/doi.org\/10.1172\/JCI39778","journal-title":"J Clin Invest"},{"key":"948_CR72","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1523\/JNEUROSCI.3556-15.2016","volume":"36","author":"A Olivas","year":"2016","unstructured":"Olivas A, Gardner RT, Wang L, Ripplinger CM, Woodward WR, Habecker BA (2016) Myocardial infarction causes transient cholinergic transdifferentiation of cardiac sympathetic nerves via gp130. J Neurosci 36:479\u2013488. https:\/\/doi.org\/10.1523\/JNEUROSCI.3556-15.2016","journal-title":"J Neurosci"},{"key":"948_CR73","doi-asserted-by":"publisher","first-page":"842656","DOI":"10.3389\/fcvm.2022.842656","volume":"9","author":"C Clyburn","year":"2022","unstructured":"Clyburn C, Andresen MC, Ingram SL, Habecker BA (2022) Untangling peripheral sympathetic neurocircuits. Front Cardiovasc Med 9:842656. https:\/\/doi.org\/10.3389\/fcvm.2022.842656","journal-title":"Front Cardiovasc Med"},{"key":"948_CR74","doi-asserted-by":"publisher","DOI":"10.1113\/JP284059","author":"C Clyburn","year":"2023","unstructured":"Clyburn C, Li MH, Ingram SL, Andresen MC, Habecker BA (2023) Cholinergic collaterals arising from noradrenergic sympathetic neurons in mice. J Physiol. https:\/\/doi.org\/10.1113\/JP284059","journal-title":"J Physiol"},{"key":"948_CR75","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1745-7254.2007.00585.x","volume":"28","author":"CS Liang","year":"2007","unstructured":"Liang CS (2007) Cardiac sympathetic nerve terminal function in congestive heart failure. Acta Pharmacol Sin 28:921\u2013927. https:\/\/doi.org\/10.1111\/j.1745-7254.2007.00585.x","journal-title":"Acta Pharmacol Sin"},{"key":"948_CR76","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1161\/01.RES.0000269828.62250.ab","volume":"100","author":"K Kimura","year":"2007","unstructured":"Kimura K, Ieda M, Kanazawa H, Yagi T, Tsunoda M, Ninomiya S, Kurosawa H, Yoshimi K, Mochizuki H, Yamazaki K, Ogawa S, Fukuda K (2007) Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 100:1755\u20131764. https:\/\/doi.org\/10.1161\/01.RES.0000269828.62250.ab","journal-title":"Circ Res"},{"key":"948_CR77","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1056\/NEJM196209272671305","volume":"267","author":"CA Chidsey","year":"1962","unstructured":"Chidsey CA, Harrison DC, Braunwald E (1962) Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med 267:650\u2013654. https:\/\/doi.org\/10.1056\/NEJM196209272671305","journal-title":"N Engl J Med"},{"key":"948_CR78","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","volume":"49","author":"TB Levine","year":"1982","unstructured":"Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN (1982) Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49:1659\u20131666. https:\/\/doi.org\/10.1016\/0002-9149(82)90243-0","journal-title":"Am J Cardiol"},{"key":"948_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","volume":"41","author":"JA Thomas","year":"1978","unstructured":"Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41:233\u2013243. https:\/\/doi.org\/10.1016\/0002-9149(78)90162-5","journal-title":"Am J Cardiol"},{"key":"948_CR80","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1161\/01.cir.93.9.1667","volume":"93","author":"G Eisenhofer","year":"1996","unstructured":"Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD (1996) Cardiac sympathetic nerve function in congestive heart failure. Circulation 93:1667\u20131676. https:\/\/doi.org\/10.1161\/01.cir.93.9.1667","journal-title":"Circulation"},{"key":"948_CR81","doi-asserted-by":"publisher","first-page":"e024850","DOI":"10.1161\/JAHA.121.024850","volume":"11","author":"T Gibbs","year":"2022","unstructured":"Gibbs T, Tapoulal N, Shanmuganathan M, Burrage MK, Borlotti A, Banning AP, Choudhury RP, Neubauer S, Kharbanda RK, Ferreira VM, Channon KM, Herring N, Ox AMIS (2022) Neuropeptide-Y levels in ST-segment-elevation myocardial infarction: relationship with coronary microvascular function, heart failure, and mortality. J Am Heart Assoc 11:e024850. https:\/\/doi.org\/10.1161\/JAHA.121.024850","journal-title":"J Am Heart Assoc"},{"key":"948_CR82","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/eurheartj\/ehz852","volume":"41","author":"M Kalla","year":"2020","unstructured":"Kalla M, Hao G, Tapoulal N, Tomek J, Liu K, Woodward L, Oxford Acute Myocardial Infarction S, Dall\u2019Armellina E, Banning AP, Choudhury RP, Neubauer S, Kharbanda RK, Channon KM, Ajijola OA, Shivkumar K, Paterson DJ, Herring N (2020) The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade. Eur Heart J 41:2168\u20132179. https:\/\/doi.org\/10.1093\/eurheartj\/ehz852","journal-title":"Eur Heart J"},{"key":"948_CR83","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/oxfordjournals.eurheartj.a060526","volume":"15","author":"B Ullman","year":"1994","unstructured":"Ullman B, Hulting J, Lundberg JM (1994) Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J 15:454\u2013461. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a060526","journal-title":"Eur Heart J"},{"key":"948_CR84","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.res.86.7.816","volume":"86","author":"JM Cao","year":"2000","unstructured":"Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen PS (2000) Nerve sprouting and sudden cardiac death. Circ Res 86:816\u2013821. https:\/\/doi.org\/10.1161\/01.res.86.7.816","journal-title":"Circ Res"},{"key":"948_CR85","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","volume":"116","author":"K Fukuda","year":"2015","unstructured":"Fukuda K, Kanazawa H, Aizawa Y, Ardell JL, Shivkumar K (2015) Cardiac innervation and sudden cardiac death. Circ Res 116:2005\u20132019. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304679","journal-title":"Circ Res"},{"key":"948_CR86","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1161\/01.res.86.7.e80","volume":"86","author":"DM Kaye","year":"2000","unstructured":"Kaye DM, Vaddadi G, Gruskin SL, Du XJ, Esler MD (2000) Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 86:E80-84. https:\/\/doi.org\/10.1161\/01.res.86.7.e80","journal-title":"Circ Res"},{"key":"948_CR87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.autneu.2010.02.005","volume":"156","author":"K Kimura","year":"2010","unstructured":"Kimura K, Kanazawa H, Ieda M, Kawaguchi-Manabe H, Miyake Y, Yagi T, Arai T, Sano M, Fukuda K (2010) Norepinephrine-induced nerve growth factor depletion causes cardiac sympathetic denervation in severe heart failure. Auton Neurosci 156:27\u201335. https:\/\/doi.org\/10.1016\/j.autneu.2010.02.005","journal-title":"Auton Neurosci"},{"key":"948_CR88","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1523\/JNEUROSCI.5866-12.2013","volume":"33","author":"RT Gardner","year":"2013","unstructured":"Gardner RT, Habecker BA (2013) Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury. J Neurosci 33:7175\u20137183. https:\/\/doi.org\/10.1523\/JNEUROSCI.5866-12.2013","journal-title":"J Neurosci"},{"key":"948_CR89","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/ncomms7235","volume":"6","author":"RT Gardner","year":"2015","unstructured":"Gardner RT, Wang L, Lang BT, Cregg JM, Dunbar CL, Woodward WR, Silver J, Ripplinger CM, Habecker BA (2015) Targeting protein tyrosine phosphatase sigma after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias. Nat Commun 6:6235. https:\/\/doi.org\/10.1038\/ncomms7235","journal-title":"Nat Commun"},{"key":"948_CR90","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.cir.87.2.454","volume":"87","author":"M Ungerer","year":"1993","unstructured":"Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454\u2013463. https:\/\/doi.org\/10.1161\/01.cir.87.2.454","journal-title":"Circulation"},{"key":"948_CR91","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1185988","volume":"327","author":"VO Nikolaev","year":"2010","unstructured":"Nikolaev VO, Moshkov A, Lyon AR, Miragoli M, Novak P, Paur H, Lohse MJ, Korchev YE, Harding SE, Gorelik J (2010) Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327:1653\u20131657. https:\/\/doi.org\/10.1126\/science.1185988","journal-title":"Science"},{"key":"948_CR92","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.107.169011","volume":"102","author":"J Desantiago","year":"2008","unstructured":"Desantiago J, Ai X, Islam M, Acuna G, Ziolo MT, Bers DM, Pogwizd SM (2008) Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load. Circ Res 102:1389\u20131397. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.169011","journal-title":"Circ Res"},{"key":"948_CR93","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCHEARTFAILURE.112.966895","volume":"5","author":"G Rengo","year":"2012","unstructured":"Rengo G, Perrone-Filardi P, Femminella GD, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Marsico F, Lymperopoulos A, Leosco D (2012) Targeting the beta-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside. Circ Heart Fail 5:385\u2013391. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.966895","journal-title":"Circ Heart Fail"},{"key":"948_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(24)01478-9","volume":"53","author":"SS Ferguson","year":"2001","unstructured":"Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1\u201324","journal-title":"Pharmacol Rev"},{"key":"948_CR95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2006.03.008","volume":"17","author":"E Reiter","year":"2006","unstructured":"Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17:159\u2013165. https:\/\/doi.org\/10.1016\/j.tem.2006.03.008","journal-title":"Trends Endocrinol Metab"},{"key":"948_CR96","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/CIRCRESAHA.119.316319","volume":"127","author":"B Xu","year":"2020","unstructured":"Xu B, Li M, Wang Y, Zhao M, Morotti S, Shi Q, Wang Q, Barbagallo F, Teoh JP, Reddy GR, Bayne EF, Liu Y, Shen A, Puglisi JL, Ge Y, Li J, Grandi E, Nieves-Cintron M, Xiang YK (2020) GRK5 controls SAP97-dependent cardiotoxic beta(1) adrenergic receptor-CaMKII signaling in heart failure. Circ Res 127:796\u2013810. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.316319","journal-title":"Circ Res"},{"key":"948_CR97","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/s0165-1838(98)00032-0","volume":"70","author":"L Gullestad","year":"1998","unstructured":"Gullestad L, Aass H, Ross H, Ueland T, Geiran O, Kjekshus J, Simonsen S, Fowler M, Kobilka B (1998) Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation. J Auton Nerv Syst 70:84\u201391. https:\/\/doi.org\/10.1016\/s0165-1838(98)00032-0","journal-title":"J Auton Nerv Syst"},{"key":"948_CR98","doi-asserted-by":"publisher","first-page":"F1811","DOI":"10.1152\/ajprenal.00191.2007","volume":"293","author":"EY Callanan","year":"2007","unstructured":"Callanan EY, Lee EW, Tilan JU, Winaver J, Haramati A, Mulroney SE, Zukowska Z (2007) Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Am J Physiol Renal Physiol 293:F1811-1817. https:\/\/doi.org\/10.1152\/ajprenal.00191.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"948_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00005344-198809000-00015","volume":"12","author":"M Bohm","year":"1988","unstructured":"Bohm M, Diet F, Feiler G, Kemkes B, Erdmann E (1988) Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol 12:357\u2013364. https:\/\/doi.org\/10.1097\/00005344-198809000-00015","journal-title":"J Cardiovasc Pharmacol"},{"key":"948_CR100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0022-3565(25)13255-2","volume":"247","author":"MR Bristow","year":"1988","unstructured":"Bristow MR, Minobe W, Rasmussen R, Hershberger RE, Hoffman BB (1988) Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 247:1039\u20131045","journal-title":"J Pharmacol Exp Ther"},{"key":"948_CR101","doi-asserted-by":"crossref","first-page":"VI1","DOI":"10.1161\/01.CIR.87.1.1","volume":"87","author":"JN Cohn","year":"1993","unstructured":"Cohn JN (1993) The vasodilator-heart failure trials (V-HeFT). Mechanistic data from the VA cooperative studies introduction. Circulation 87:VI1-4","journal-title":"Circulation"},{"key":"948_CR102","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.amjcard.2009.03.030","volume":"104","author":"AS Dhaliwal","year":"2009","unstructured":"Dhaliwal AS, Habib G, Deswal A, Verduzco M, Souchek J, Ramasubbu K, Aguilar D, Ma TS, Jneid HM, Bolos M, Bozkurt B (2009) Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol 104:270\u2013275. https:\/\/doi.org\/10.1016\/j.amjcard.2009.03.030","journal-title":"Am J Cardiol"},{"key":"948_CR103","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/ncpcardio1130","volume":"5","author":"RD Nass","year":"2008","unstructured":"Nass RD, Aiba T, Tomaselli GF, Akar FG (2008) Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat Clin Pract Cardiovasc Med 5:196\u2013207. https:\/\/doi.org\/10.1038\/ncpcardio1130","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"948_CR104","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/physrev.00014.2006","volume":"87","author":"S Nattel","year":"2007","unstructured":"Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425\u2013456. https:\/\/doi.org\/10.1152\/physrev.00014.2006","journal-title":"Physiol Rev"},{"key":"948_CR105","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/j.jacc.2009.12.066","volume":"55","author":"MJ Boogers","year":"2010","unstructured":"Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769\u20132777. https:\/\/doi.org\/10.1016\/j.jacc.2009.12.066","journal-title":"J Am Coll Cardiol"},{"key":"948_CR106","doi-asserted-by":"publisher","first-page":"e006446","DOI":"10.1161\/CIRCIMAGING.117.006446","volume":"10","author":"JA Fallavollita","year":"2017","unstructured":"Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM Jr (2017) Denervated myocardium is preferentially associated with sudden cardiac arrest in ischemic cardiomyopathy: a pilot competing risks analysis of cause-specific mortality. Circ Cardiovasc Imaging 10:e006446. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.006446","journal-title":"Circ Cardiovasc Imaging"},{"key":"948_CR107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","volume":"63","author":"JA Fallavollita","year":"2014","unstructured":"Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME, Canty JM Jr (2014) Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 63:141\u2013149. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.096","journal-title":"J Am Coll Cardiol"},{"key":"948_CR108","doi-asserted-by":"publisher","first-page":"H1838","DOI":"10.1152\/ajpheart.01106.2011","volume":"302","author":"M Vaseghi","year":"2012","unstructured":"Vaseghi M, Lux RL, Mahajan A, Shivkumar K (2012) Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am J Physiol Heart Circ Physiol 302:H1838-1846. https:\/\/doi.org\/10.1152\/ajpheart.01106.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR109","doi-asserted-by":"publisher","first-page":"H815","DOI":"10.1152\/ajpheart.1993.264.3.H815","volume":"264","author":"MR Warner","year":"1993","unstructured":"Warner MR, Wisler PL, Hodges TD, Watanabe AM, Zipes DP (1993) Mechanisms of denervation supersensitivity in regionally denervated canine hearts. Am J Physiol 264:H815-820. https:\/\/doi.org\/10.1152\/ajpheart.1993.264.3.H815","journal-title":"Am J Physiol"},{"key":"948_CR110","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCRESAHA.113.302982","volume":"114","author":"M Aflaki","year":"2014","unstructured":"Aflaki M, Qi XY, Xiao L, Ordog B, Tadevosyan A, Luo X, Maguy A, Shi Y, Tardif JC, Nattel S (2014) Exchange protein directly activated by cAMP mediates slow delayed-rectifier current remodeling by sustained beta-adrenergic activation in guinea pig hearts. Circ Res 114:993\u20131003. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302982","journal-title":"Circ Res"},{"key":"948_CR111","doi-asserted-by":"publisher","first-page":"18801","DOI":"10.1038\/s41598-020-75903-y","volume":"10","author":"S Tapa","year":"2020","unstructured":"Tapa S, Wang L, Francis Stuart SD, Wang Z, Jiang Y, Habecker BA, Ripplinger CM (2020) Adrenergic supersensitivity and impaired neural control of cardiac electrophysiology following regional cardiac sympathetic nerve loss. Sci Rep 10:18801. https:\/\/doi.org\/10.1038\/s41598-020-75903-y","journal-title":"Sci Rep"},{"key":"948_CR112","doi-asserted-by":"publisher","first-page":"e86715","DOI":"10.1172\/jci.insight.86715","volume":"2","author":"M Vaseghi","year":"2017","unstructured":"Vaseghi M, Salavatian S, Rajendran PS, Yagishita D, Woodward WR, Hamon D, Yamakawa K, Irie T, Habecker BA, Shivkumar K (2017) Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction. JCI Insight 2:e86715. https:\/\/doi.org\/10.1172\/jci.insight.86715","journal-title":"JCI Insight"},{"key":"948_CR113","doi-asserted-by":"publisher","first-page":"A14090","DOI":"10.1161\/circ.144.suppl_1.14090","volume":"144","author":"Z Lokhandwala","year":"2021","unstructured":"Lokhandwala Z, Devarajan A, Wang K, Shannon K, Tompkins JD, Vaseghi M (2021) Abstract: myocardial infarction selectively decreases cardiac vagal afferent neurotransmission: implications for mechanisms behind cardiac parasympathetic dysfunction. Circulation 144:A14090. https:\/\/doi.org\/10.1161\/circ.144.suppl_1.14090","journal-title":"Circulation"},{"key":"948_CR114","doi-asserted-by":"publisher","first-page":"H1632","DOI":"10.1152\/ajpheart.01051.2002","volume":"285","author":"ME Dunlap","year":"2003","unstructured":"Dunlap ME, Bibevski S, Rosenberry TL, Ernsberger P (2003) Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am J Physiol Heart Circ Physiol 285:H1632-1640. https:\/\/doi.org\/10.1152\/ajpheart.01051.2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR115","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCIMAGING.108.822106","volume":"2","author":"AN Mazzadi","year":"2009","unstructured":"Mazzadi AN, Pineau J, Costes N, Le Bars D, Bonnefoi F, Croisille P, Porcher R, Chevalier P (2009) Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging 2:365\u2013372. https:\/\/doi.org\/10.1161\/CIRCIMAGING.108.822106","journal-title":"Circ Cardiovasc Imaging"},{"key":"948_CR116","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2012.09.067","volume":"168","author":"B He","year":"2013","unstructured":"He B, Lu Z, He W, Wu L, Cui B, Hu X, Yu L, Huang C, Jiang H (2013) Effects of ganglionated plexi ablation on ventricular electrophysiological properties in normal hearts and after acute myocardial ischemia. Int J Cardiol 168:86\u201393. https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.067","journal-title":"Int J Cardiol"},{"key":"948_CR117","doi-asserted-by":"publisher","first-page":"14155","DOI":"10.1038\/ncomms14155","volume":"8","author":"C Jungen","year":"2017","unstructured":"Jungen C, Scherschel K, Eickholt C, Kuklik P, Klatt N, Bork N, Salzbrunn T, Alken F, Angendohr S, Klene C, Mester J, Klocker N, Veldkamp MW, Schumacher U, Willems S, Nikolaev VO, Meyer C (2017) Disruption of cardiac cholinergic neurons enhances susceptibility to ventricular arrhythmias. Nat Commun 8:14155. https:\/\/doi.org\/10.1038\/ncomms14155","journal-title":"Nat Commun"},{"key":"948_CR118","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jce.13912","volume":"30","author":"B Wu","year":"2019","unstructured":"Wu B, Xu S, Dai R, Hong M, Wu H, Lin R (2019) Epicardial ganglionated plexi ablation increases the inducibility of ventricular tachyarrhythmias in a canine postmyocardial infarction model. J Cardiovasc Electrophysiol 30:741\u2013746. https:\/\/doi.org\/10.1111\/jce.13912","journal-title":"J Cardiovasc Electrophysiol"},{"key":"948_CR119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","volume":"389","author":"NCDRF Collaboration","year":"2017","unstructured":"Collaboration NCDRF (2017) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 389:37\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(16)31919-5","journal-title":"Lancet"},{"key":"948_CR120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11906-014-0519-8","volume":"17","author":"M Esler","year":"2015","unstructured":"Esler M (2015) The sympathetic nervous system in hypertension: back to the future? Curr Hypertens Rep 17:11. https:\/\/doi.org\/10.1007\/s11906-014-0519-8","journal-title":"Curr Hypertens Rep"},{"key":"948_CR121","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/HYPERTENSIONAHA.108.119883","volume":"54","author":"G Grassi","year":"2009","unstructured":"Grassi G (2009) Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54:690\u2013697. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.119883","journal-title":"Hypertension"},{"key":"948_CR122","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/01.cir.100.12.1305","volume":"100","author":"JP Greenwood","year":"1999","unstructured":"Greenwood JP, Stoker JB, Mary DA (1999) Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation 100:1305\u20131310. https:\/\/doi.org\/10.1161\/01.cir.100.12.1305","journal-title":"Circulation"},{"key":"948_CR123","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","volume":"108","author":"MP Schlaich","year":"2003","unstructured":"Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD (2003) Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108:560\u2013565. https:\/\/doi.org\/10.1161\/01.CIR.0000081775.72651.B6","journal-title":"Circulation"},{"key":"948_CR124","first-page":"S77","volume":"8","author":"J de Champlain","year":"1990","unstructured":"de Champlain J (1990) Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens Suppl 8:S77-85","journal-title":"J Hypertens Suppl"},{"key":"948_CR125","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00004872-198504000-00003","volume":"3","author":"MD Esler","year":"1985","unstructured":"Esler MD, Hasking GJ, Willett IR, Leonard PW, Jennings GL (1985) Noradrenaline release and sympathetic nervous system activity. J Hypertens 3:117\u2013129. https:\/\/doi.org\/10.1097\/00004872-198504000-00003","journal-title":"J Hypertens"},{"key":"948_CR126","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","volume":"42","author":"K Masuo","year":"2003","unstructured":"Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML (2003) Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42:474\u2013480. https:\/\/doi.org\/10.1161\/01.HYP.0000091371.53502.D3","journal-title":"Hypertension"},{"key":"948_CR127","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/01.hyp.32.2.293","volume":"32","author":"JP Singh","year":"1998","unstructured":"Singh JP, Larson MG, Tsuji H, Evans JC, O\u2019Donnell CJ, Levy D (1998) Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 32:293\u2013297. https:\/\/doi.org\/10.1161\/01.hyp.32.2.293","journal-title":"Hypertension"},{"key":"948_CR128","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/jhh.2011.66","volume":"26","author":"JP Fisher","year":"2012","unstructured":"Fisher JP, Paton JF (2012) The sympathetic nervous system and blood pressure in humans: implications for hypertension. J Hum Hypertens 26:463\u2013475. https:\/\/doi.org\/10.1038\/jhh.2011.66","journal-title":"J Hum Hypertens"},{"key":"948_CR129","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pbiomolbio.2003.11.010","volume":"84","author":"IH Zucker","year":"2004","unstructured":"Zucker IH, Schultz HD, Li YF, Wang Y, Wang W, Patel KP (2004) The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 84:217\u2013232. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2003.11.010","journal-title":"Prog Biophys Mol Biol"},{"key":"948_CR130","doi-asserted-by":"publisher","first-page":"38898","DOI":"10.1038\/srep38898","volume":"6","author":"HE Larsen","year":"2016","unstructured":"Larsen HE, Lefkimmiatis K, Paterson DJ (2016) Sympathetic neurons are a powerful driver of myocyte function in cardiovascular disease. Sci Rep 6:38898. https:\/\/doi.org\/10.1038\/srep38898","journal-title":"Sci Rep"},{"key":"948_CR131","doi-asserted-by":"publisher","first-page":"H980","DOI":"10.1152\/ajpheart.00255.2013","volume":"305","author":"J Shanks","year":"2013","unstructured":"Shanks J, Manou-Stathopoulou S, Lu CJ, Li D, Paterson DJ, Herring N (2013) Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 305:H980-986. https:\/\/doi.org\/10.1152\/ajpheart.00255.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR132","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00041552-200203000-00011","volume":"11","author":"GF DiBona","year":"2002","unstructured":"DiBona GF (2002) Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11:197\u2013200. https:\/\/doi.org\/10.1097\/00041552-200203000-00011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"948_CR133","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275\u20131281. https:\/\/doi.org\/10.1016\/S0140-6736(09)60566-3","journal-title":"Lancet"},{"key":"948_CR134","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMc0904179","volume":"361","author":"MP Schlaich","year":"2009","unstructured":"Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932\u2013934. https:\/\/doi.org\/10.1056\/NEJMc0904179","journal-title":"N Engl J Med"},{"key":"948_CR135","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/HYPERTENSIONAHA.111.186460","volume":"59","author":"D Li","year":"2012","unstructured":"Li D, Lee CW, Buckler K, Parekh A, Herring N, Paterson DJ (2012) Abnormal intracellular calcium homeostasis in sympathetic neurons from young prehypertensive rats. Hypertension 59:642\u2013649. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.186460","journal-title":"Hypertension"},{"key":"948_CR136","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00004872-200307000-00026","volume":"21","author":"C Zugck","year":"2003","unstructured":"Zugck C, Lossnitzer D, Backs J, Kristen A, Kinscherf R, Haass M (2003) Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors. J Hypertens 21:1363\u20131369. https:\/\/doi.org\/10.1097\/00004872-200307000-00026","journal-title":"J Hypertens"},{"key":"948_CR137","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/HYPERTENSIONAHA.112.202184","volume":"61","author":"J Shanks","year":"2013","unstructured":"Shanks J, Mane S, Ryan R, Paterson DJ (2013) Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat. Hypertension 61:187\u2013193. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.202184","journal-title":"Hypertension"},{"key":"948_CR138","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.hyp.29.3.715","volume":"29","author":"M Castellano","year":"1997","unstructured":"Castellano M, Bohm M (1997) The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension 29:715\u2013722. https:\/\/doi.org\/10.1161\/01.hyp.29.3.715","journal-title":"Hypertension"},{"key":"948_CR139","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11906-009-0035-4","volume":"11","author":"P Palatini","year":"2009","unstructured":"Palatini P, Julius S (2009) The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep 11:199\u2013205. https:\/\/doi.org\/10.1007\/s11906-009-0035-4","journal-title":"Curr Hypertens Rep"},{"key":"948_CR140","first-page":"611","volume":"30","author":"M Bohm","year":"1995","unstructured":"Bohm M, Kirchmayr R, Erdmann E (1995) Myocardial Gi alpha-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc Res 30:611\u2013618","journal-title":"Cardiovasc Res"},{"key":"948_CR141","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1097\/01.hjh.0000249685.58370.28","volume":"24","author":"HA Bradley","year":"2006","unstructured":"Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH (2006) How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 24:2131\u20132141. https:\/\/doi.org\/10.1097\/01.hjh.0000249685.58370.28","journal-title":"J Hypertens"},{"key":"948_CR142","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s0895-7061(99)00005-9","volume":"12","author":"JD Blumenfeld","year":"1999","unstructured":"Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH (1999) Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Am J Hypertens 12:451\u2013459. https:\/\/doi.org\/10.1016\/s0895-7061(99)00005-9","journal-title":"Am J Hypertens"},{"key":"948_CR143","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","volume":"23","author":"JD Sipe","year":"2016","unstructured":"Sipe JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJ, Westermark P (2016) Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification international society of amyloidosis 2016 nomenclature guidelines. Amyloid 23:209\u2013213. https:\/\/doi.org\/10.1080\/13506129.2016.1257986","journal-title":"Amyloid"},{"key":"948_CR144","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/s0735-1097(85)80475-7","volume":"6","author":"L Cueto-Garcia","year":"1985","unstructured":"Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, Offord KP, Greipp PR, Edwards WD, Tajik AJ (1985) Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6:737\u2013743. https:\/\/doi.org\/10.1016\/s0735-1097(85)80475-7","journal-title":"J Am Coll Cardiol"},{"key":"948_CR145","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0022-510x(87)90267-x","volume":"79","author":"S Ikeda","year":"1987","unstructured":"Ikeda S, Yanagisawa N, Hongo M, Ito N (1987) Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 79:129\u2013139. https:\/\/doi.org\/10.1016\/0022-510x(87)90267-x","journal-title":"J Neurol Sci"},{"key":"948_CR146","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ncn3.12601","volume":"10","author":"S-i Ikeda","year":"2022","unstructured":"Ikeda S-i (2022) Amyloid neuropathy and autonomic dysfunction. Neurol Clin Neurosci 10:137\u2013146. https:\/\/doi.org\/10.1111\/ncn3.12601","journal-title":"Neurol Clin Neurosci"},{"key":"948_CR147","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/heart.88.6.615","volume":"88","author":"L Bernardi","year":"2002","unstructured":"Bernardi L, Passino C, Porta C, Anesi E, Palladini G, Merlini G (2002) Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? Heart 88:615\u2013621. https:\/\/doi.org\/10.1136\/heart.88.6.615","journal-title":"Heart"},{"issue":"Suppl 1","key":"948_CR148","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.amjmed.2022.02.005","volume":"135","author":"P King","year":"2022","unstructured":"King P, Kates AM (2022) Management of cardiac symptoms in amyloidosis. Am J Med 135(Suppl 1):S9\u2013S12. https:\/\/doi.org\/10.1016\/j.amjmed.2022.02.005","journal-title":"Am J Med"},{"key":"948_CR149","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/13506129609045517","volume":"3","author":"F Gemmi","year":"1996","unstructured":"Gemmi F, Miliani A, Bergesio F, Salvadori M, Merlini G (1996) Functional study of autonomic neuropathy in primary (AL) amyloidosis. Amyloid 3:167\u2013172. https:\/\/doi.org\/10.3109\/13506129609045517","journal-title":"Amyloid"},{"key":"948_CR150","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/euhj.2001.2972","volume":"23","author":"AK Reyners","year":"2002","unstructured":"Reyners AK, Hazenberg BP, Reitsma WD, Smit AJ (2002) Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis. Eur Heart J 23:157\u2013161. https:\/\/doi.org\/10.1053\/euhj.2001.2972","journal-title":"Eur Heart J"},{"key":"948_CR151","doi-asserted-by":"publisher","first-page":"e12749","DOI":"10.1111\/anec.12749","volume":"25","author":"S Yamada","year":"2020","unstructured":"Yamada S, Yoshihisa A, Hijioka N, Kamioka M, Kaneshiro T, Yokokawa T, Misaka T, Ishida T, Takeishi Y (2020) Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence. Ann Noninvasive Electrocardiol 25:e12749. https:\/\/doi.org\/10.1111\/anec.12749","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"948_CR152","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40256-020-00461-7","volume":"21","author":"YN Lamb","year":"2021","unstructured":"Lamb YN (2021) Tafamidis: a review in transthyretin amyloid cardiomyopathy. Am J Cardiovasc Drugs 21:113\u2013121. https:\/\/doi.org\/10.1007\/s40256-020-00461-7","journal-title":"Am J Cardiovasc Drugs"},{"key":"948_CR153","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C, Investigators A-AS (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379:1007\u20131016. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"948_CR154","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14797\/mdcvj.1050","volume":"18","author":"LK Stern","year":"2022","unstructured":"Stern LK, Patel J (2022) Cardiac amyloidosis treatment. Methodist Debakey Cardiovasc J 18:59\u201372. https:\/\/doi.org\/10.14797\/mdcvj.1050","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"948_CR155","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/europace\/euaa094","volume":"22","author":"EJ Kim","year":"2020","unstructured":"Kim EJ, Holmes BB, Huang S, Lugo R, Al Aboud A, Goodman S, Hung RR, Slosky D, Stevenson WG, Michaud GF, John RM (2020) Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator. Europace 22:1216\u20131223. https:\/\/doi.org\/10.1093\/europace\/euaa094","journal-title":"Europace"},{"key":"948_CR156","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/jce.12123","volume":"24","author":"G Lin","year":"2013","unstructured":"Lin G, Dispenzieri A, Kyle R, Grogan M, Brady PA (2013) Implantable cardioverter defibrillators in patients with cardiac amyloidosis. J Cardiovasc Electrophysiol 24:793\u2013798. https:\/\/doi.org\/10.1111\/jce.12123","journal-title":"J Cardiovasc Electrophysiol"},{"key":"948_CR157","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrcardio.2015.39","volume":"12","author":"YJ Akashi","year":"2015","unstructured":"Akashi YJ, Nef HM, Lyon AR (2015) Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol 12:387\u2013397. https:\/\/doi.org\/10.1038\/nrcardio.2015.39","journal-title":"Nat Rev Cardiol"},{"key":"948_CR158","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ejhf.424","volume":"18","author":"AR Lyon","year":"2016","unstructured":"Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E (2016) Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the heart failure association of the European society of cardiology. Eur J Heart Fail 18:8\u201327. https:\/\/doi.org\/10.1002\/ejhf.424","journal-title":"Eur J Heart Fail"},{"key":"948_CR159","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jacc.2020.10.060","volume":"77","author":"AR Lyon","year":"2021","unstructured":"Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C, Omerovic E (2021) Pathophysiology of Takotsubo syndrome: JACC state-of-the-art review. J Am Coll Cardiol 77:902\u2013921. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.060","journal-title":"J Am Coll Cardiol"},{"key":"948_CR160","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijcard.2014.04.103","volume":"174","author":"B Redfors","year":"2014","unstructured":"Redfors B, Ali A, Shao Y, Lundgren J, Gan LM, Omerovic E (2014) Different catecholamines induce different patterns of Takotsubo-like cardiac dysfunction in an apparently afterload dependent manner. Int J Cardiol 174:330\u2013336. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.103","journal-title":"Int J Cardiol"},{"key":"948_CR161","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa043046","volume":"352","author":"IS Wittstein","year":"2005","unstructured":"Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539\u2013548. https:\/\/doi.org\/10.1056\/NEJMoa043046","journal-title":"N Engl J Med"},{"key":"948_CR162","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","volume":"39","author":"JR Ghadri","year":"2018","unstructured":"Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Yh S, Migliore F, Horowitz JD, Shimokawa H, Luscher TF, Templin C (2018) International expert consensus document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 39:2032\u20132046. https:\/\/doi.org\/10.1093\/eurheartj\/ehy076","journal-title":"Eur Heart J"},{"key":"948_CR163","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.jacc.2010.03.107","volume":"56","author":"EA Martin","year":"2010","unstructured":"Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A (2010) Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol 56:1840\u20131846. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.107","journal-title":"J Am Coll Cardiol"},{"key":"948_CR164","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijcard.2014.01.052","volume":"172","author":"B Redfors","year":"2014","unstructured":"Redfors B, Shao Y, Ali A, Omerovic E (2014) Are ischemic stunning, conditioning, and \u201cTakotsubo\u201d different sides to the same coin? Int J Cardiol 172:490\u2013491. https:\/\/doi.org\/10.1016\/j.ijcard.2014.01.052","journal-title":"Int J Cardiol"},{"key":"948_CR165","doi-asserted-by":"publisher","first-page":"H1487","DOI":"10.1152\/ajpheart.00443.2014","volume":"307","author":"S Land","year":"2014","unstructured":"Land S, Niederer SA, Louch WE, Roe AT, Aronsen JM, Stuckey DJ, Sikkel MB, Tranter MH, Lyon AR, Harding SE, Smith NP (2014) Computational modeling of Takotsubo cardiomyopathy: effect of spatially varying beta-adrenergic stimulation in the rat left ventricle. Am J Physiol Heart Circ Physiol 307:H1487-1496. https:\/\/doi.org\/10.1152\/ajpheart.00443.2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR166","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCULATIONAHA.112.111591","volume":"126","author":"H Paur","year":"2012","unstructured":"Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O\u2019Gara P, Stuckey DJ, Nikolaev VO, Diakonov I, Pannell L, Gong H, Sun H, Peters NS, Petrou M, Zheng Z, Gorelik J, Lyon AR, Harding SE (2012) High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor\/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 126:697\u2013706. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.111591","journal-title":"Circulation"},{"key":"948_CR167","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jacc.2017.06.061","volume":"70","author":"T Borchert","year":"2017","unstructured":"Borchert T, Hubscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, Tiburcy M, Liaw NY, Li Y, Haas J, Sossalla S, Huber MA, Cyganek L, Jacobshagen C, Dressel R, Raaz U, Nikolaev VO, Guan K, Thiele H, Meder B, Wollnik B, Zimmermann WH, Luscher TF, Hasenfuss G, Templin C, Streckfuss-Bomeke K (2017) Catecholamine-dependent beta-adrenergic signaling in a pluripotent stem cell model of Takotsubo cardiomyopathy. J Am Coll Cardiol 70:975\u2013991. https:\/\/doi.org\/10.1016\/j.jacc.2017.06.061","journal-title":"J Am Coll Cardiol"},{"key":"948_CR168","doi-asserted-by":"publisher","first-page":"e93278","DOI":"10.1371\/journal.pone.0093278","volume":"9","author":"A Vaccaro","year":"2014","unstructured":"Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, Labrunee M, Guiraud T, Esler M, Galinier M, Senard JM, Pathak A (2014) Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS ONE 9:e93278. https:\/\/doi.org\/10.1371\/journal.pone.0093278","journal-title":"PLoS ONE"},{"key":"948_CR169","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/qjmed\/hcm028","volume":"100","author":"YJ Akashi","year":"2007","unstructured":"Akashi YJ, Barbaro G, Sakurai T, Nakazawa K, Miyake F (2007) Cardiac autonomic imbalance in patients with reversible ventricular dysfunction Takotsubo cardiomyopathy. QJM 100:335\u2013343. https:\/\/doi.org\/10.1093\/qjmed\/hcm028","journal-title":"QJM"},{"issue":"Suppl 1","key":"948_CR170","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1111\/j.1540-8159.2008.02221.x","volume":"32","author":"J Ortak","year":"2009","unstructured":"Ortak J, Khattab K, Barantke M, Wiegand UK, Bansch D, Ince H, Nienaber CA, Bonnemeier H (2009) Evolution of cardiac autonomic nervous activity indices in patients presenting with transient left ventricular apical ballooning. Pacing Clin Electrophysiol 32(Suppl 1):S21-25. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.02221.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"948_CR171","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijcard.2015.03.162","volume":"185","author":"B Redfors","year":"2015","unstructured":"Redfors B, Vedad R, Angeras O, Ramunddal T, Petursson P, Haraldsson I, Ali A, Dworeck C, Odenstedt J, Ioaness D, Libungan B, Shao Y, Albertsson P, Stone GW, Omerovic E (2015) Mortality in Takotsubo syndrome is similar to mortality in myocardial infarction\u2014a report from the SWEDEHEART registry. Int J Cardiol 185:282\u2013289. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.162","journal-title":"Int J Cardiol"},{"key":"948_CR172","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ejhf.494","volume":"18","author":"T Stiermaier","year":"2016","unstructured":"Stiermaier T, Moeller C, Oehler K, Desch S, Graf T, Eitel C, Vonthein R, Schuler G, Thiele H, Eitel I (2016) Long-term excess mortality in Takotsubo cardiomyopathy: predictors, causes and clinical consequences. Eur J Heart Fail 18:650\u2013656. https:\/\/doi.org\/10.1002\/ejhf.494","journal-title":"Eur J Heart Fail"},{"key":"948_CR173","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.amjcard.2015.10.028","volume":"117","author":"L Norcliffe-Kaufmann","year":"2016","unstructured":"Norcliffe-Kaufmann L, Kaufmann H, Martinez J, Katz SD, Tully L, Reynolds HR (2016) Autonomic findings in Takotsubo cardiomyopathy. Am J Cardiol 117:206\u2013213. https:\/\/doi.org\/10.1016\/j.amjcard.2015.10.028","journal-title":"Am J Cardiol"},{"key":"948_CR174","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.jacc.2018.07.072","volume":"72","author":"H Medina de Chazal","year":"2018","unstructured":"Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, Abbate A (2018) Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol 72:1955\u20131971. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.072","journal-title":"J Am Coll Cardiol"},{"key":"948_CR175","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/clc.22280","volume":"37","author":"F Santoro","year":"2014","unstructured":"Santoro F, Ieva R, Musaico F, Ferraretti A, Triggiani G, Tarantino N, Di Biase M, Brunetti ND (2014) Lack of efficacy of drug therapy in preventing Takotsubo cardiomyopathy recurrence: a meta-analysis. Clin Cardiol 37:434\u2013439. https:\/\/doi.org\/10.1002\/clc.22280","journal-title":"Clin Cardiol"},{"key":"948_CR176","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijcard.2014.04.221","volume":"174","author":"K Singh","year":"2014","unstructured":"Singh K, Carson K, Usmani Z, Sawhney G, Shah R, Horowitz J (2014) Systematic review and meta-analysis of incidence and correlates of recurrence of Takotsubo cardiomyopathy. Int J Cardiol 174:696\u2013701. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.221","journal-title":"Int J Cardiol"},{"key":"948_CR177","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","volume":"373","author":"C Templin","year":"2015","unstructured":"Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschope C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Bohm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Luscher TF (2015) Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 373:929\u2013938. https:\/\/doi.org\/10.1056\/NEJMoa1406761","journal-title":"N Engl J Med"},{"key":"948_CR178","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJM199705293362207","volume":"336","author":"MJ Ackerman","year":"1997","unstructured":"Ackerman MJ, Clapham DE (1997) Ion channels\u2014basic science and clinical disease. N Engl J Med 336:1575\u20131586. https:\/\/doi.org\/10.1056\/NEJM199705293362207","journal-title":"N Engl J Med"},{"key":"948_CR179","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0092-8674(01)00243-4","volume":"104","author":"MT Keating","year":"2001","unstructured":"Keating MT, Sanguinetti MC (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569\u2013580. https:\/\/doi.org\/10.1016\/s0092-8674(01)00243-4","journal-title":"Cell"},{"key":"948_CR180","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/01.cir.71.1.17","volume":"71","author":"AJ Moss","year":"1985","unstructured":"Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E (1985) The long QT syndrome: a prospective international study. Circulation 71:17\u201321. https:\/\/doi.org\/10.1161\/01.cir.71.1.17","journal-title":"Circulation"},{"key":"948_CR181","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1001\/jama.294.23.2975","volume":"294","author":"C Napolitano","year":"2005","unstructured":"Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, Bottelli G, Cerrone M, Leonardi S (2005) Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 294:2975\u20132980. https:\/\/doi.org\/10.1001\/jama.294.23.2975","journal-title":"JAMA"},{"key":"948_CR182","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1540-8167.2001.00500.x","volume":"12","author":"PJ Schwartz","year":"2001","unstructured":"Schwartz PJ (2001) Another role for the sympathetic nervous system in the long QT syndrome? J Cardiovasc Electrophysiol 12:500\u2013502. https:\/\/doi.org\/10.1046\/j.1540-8167.2001.00500.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"948_CR183","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/s0002-9149(99)00458-0","volume":"84","author":"AJ Moss","year":"1999","unstructured":"Moss AJ, Robinson JL, Gessman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K (1999) Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 84:876\u2013879. https:\/\/doi.org\/10.1016\/s0002-9149(99)00458-0","journal-title":"Am J Cardiol"},{"key":"948_CR184","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/nyas.14425","volume":"1474","author":"K Saadeh","year":"2020","unstructured":"Saadeh K, Shivkumar K, Jeevaratnam K (2020) Targeting the beta-adrenergic receptor in the clinical management of congenital long QT syndrome. Ann N Y Acad Sci 1474:27\u201346. https:\/\/doi.org\/10.1111\/nyas.14425","journal-title":"Ann N Y Acad Sci"},{"key":"948_CR185","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/euhj.2001.3079","volume":"23","author":"T Noda","year":"2002","unstructured":"Noda T, Takaki H, Kurita T, Suyama K, Nagaya N, Taguchi A, Aihara N, Kamakura S, Sunagawa K, Nakamura K, Ohe T, Horie M, Napolitano C, Towbin JA, Priori SG, Shimizu W (2002) Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 23:975\u2013983. https:\/\/doi.org\/10.1053\/euhj.2001.3079","journal-title":"Eur Heart J"},{"key":"948_CR186","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/s0735-1097(99)00582-3","volume":"35","author":"W Shimizu","year":"2000","unstructured":"Shimizu W, Antzelevitch C (2000) Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35:778\u2013786. https:\/\/doi.org\/10.1016\/s0735-1097(99)00582-3","journal-title":"J Am Coll Cardiol"},{"key":"948_CR187","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s0735-1097(02)02850-4","volume":"41","author":"W Shimizu","year":"2003","unstructured":"Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K, Suyama K, Aihara N, Kamakura S, Sunagawa K, Echigo S, Nakamura K, Ohe T, Towbin JA, Napolitano C, Priori SG (2003) Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 41:633\u2013642. https:\/\/doi.org\/10.1016\/s0735-1097(02)02850-4","journal-title":"J Am Coll Cardiol"},{"key":"948_CR188","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/s0735-1097(99)00255-7","volume":"34","author":"H Swan","year":"1999","unstructured":"Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L (1999) Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 34:823\u2013829. https:\/\/doi.org\/10.1016\/s0735-1097(99)00255-7","journal-title":"J Am Coll Cardiol"},{"key":"948_CR189","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.cir.0000048142.85076.a2","volume":"107","author":"K Takenaka","year":"2003","unstructured":"Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, Kamakura S, Horie M (2003) Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 107:838\u2013844. https:\/\/doi.org\/10.1161\/01.cir.0000048142.85076.a2","journal-title":"Circulation"},{"key":"948_CR190","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4065\/77.5.413","volume":"77","author":"MJ Ackerman","year":"2002","unstructured":"Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB (2002) Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 77:413\u2013421. https:\/\/doi.org\/10.4065\/77.5.413","journal-title":"Mayo Clin Proc"},{"key":"948_CR191","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/s0735-1097(00)01200-6","volume":"37","author":"Y Tanabe","year":"2001","unstructured":"Tanabe Y, Inagaki M, Kurita T, Nagaya N, Taguchi A, Suyama K, Aihara N, Kamakura S, Sunagawa K, Nakamura K, Ohe T, Towbin JA, Priori SG, Shimizu W (2001) Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 37:911\u2013919. https:\/\/doi.org\/10.1016\/s0735-1097(00)01200-6","journal-title":"J Am Coll Cardiol"},{"key":"948_CR192","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCEP.113.001184","volume":"7","author":"S Rizzo","year":"2014","unstructured":"Rizzo S, Basso C, Troost D, Aronica E, Frigo AC, Driessen AH, Thiene G, Wilde AA, van der Wal AC (2014) T-cell-mediated inflammatory activity in the stellate ganglia of patients with ion-channel disease and severe ventricular arrhythmias. Circ Arrhythm Electrophysiol 7:224\u2013229. https:\/\/doi.org\/10.1161\/CIRCEP.113.001184","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"948_CR193","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00259-011-1852-7","volume":"38","author":"P Kies","year":"2011","unstructured":"Kies P, Paul M, Gerss J, Stegger L, Monnig G, Schober O, Wichter T, Schafers M, Schulze-Bahr E (2011) Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome. Eur J Nucl Med Mol Imaging 38:1899\u20131907. https:\/\/doi.org\/10.1007\/s00259-011-1852-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"948_CR194","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/eurheartj\/14.3.316","volume":"14","author":"KD Muller","year":"1993","unstructured":"Muller KD, Jakob H, Neuzner J, Grebe SF, Schlepper M, Pitschner HF (1993) 123I-metaiodobenzylguanidine scintigraphy in the detection of irregular regional sympathetic innervation in long QT syndrome. Eur Heart J 14:316\u2013325. https:\/\/doi.org\/10.1093\/eurheartj\/14.3.316","journal-title":"Eur Heart J"},{"key":"948_CR195","doi-asserted-by":"publisher","first-page":"e0185680","DOI":"10.1371\/journal.pone.0185680","volume":"12","author":"J Ahn","year":"2017","unstructured":"Ahn J, Kim HJ, Choi JI, Lee KN, Shim J, Ahn HS, Kim YH (2017) Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: a meta-analysis. PLoS ONE 12:e0185680. https:\/\/doi.org\/10.1371\/journal.pone.0185680","journal-title":"PLoS ONE"},{"key":"948_CR196","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1161\/CIRCULATIONAHA.106.665406","volume":"115","author":"AJ Moss","year":"2007","unstructured":"Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S (2007) Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 115:2481\u20132489. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.665406","journal-title":"Circulation"},{"key":"948_CR197","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/01.cir.101.6.616","volume":"101","author":"AJ Moss","year":"2000","unstructured":"Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101:616\u2013623. https:\/\/doi.org\/10.1161\/01.cir.101.6.616","journal-title":"Circulation"},{"key":"948_CR198","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","volume":"292","author":"SG Priori","year":"2004","unstructured":"Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, Moncalvo C, Tulipani C, Veia A, Bottelli G, Nastoli J (2004) Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292:1341\u20131344. https:\/\/doi.org\/10.1001\/jama.292.11.1341","journal-title":"JAMA"},{"key":"948_CR199","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","volume":"6","author":"PJ Schwartz","year":"2020","unstructured":"Schwartz PJ, Ackerman MJ, Antzelevitch C, Bezzina CR, Borggrefe M, Cuneo BF, Wilde AAM (2020) Inherited cardiac arrhythmias. Nat Rev Dis Primers 6:58. https:\/\/doi.org\/10.1038\/s41572-020-0188-7","journal-title":"Nat Rev Dis Primers"},{"key":"948_CR200","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.jacc.2009.08.028","volume":"54","author":"W Shimizu","year":"2009","unstructured":"Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S (2009) Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 54:2052\u20132062. https:\/\/doi.org\/10.1016\/j.jacc.2009.08.028","journal-title":"J Am Coll Cardiol"},{"key":"948_CR201","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1540-8183.1995.tb00930.x","volume":"8","author":"GM De Ferrari","year":"1995","unstructured":"De Ferrari GM, Locati EH, Priori SG, Schwartz PJ (1995) Left cardiac sympathetic denervation in long QT syndrome patients. J Interv Cardiol 8:776\u2013781. https:\/\/doi.org\/10.1111\/j.1540-8183.1995.tb00930.x","journal-title":"J Interv Cardiol"},{"key":"948_CR202","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcvm.2019.00027","volume":"6","author":"V Dusi","year":"2019","unstructured":"Dusi V, De Ferrari GM, Pugliese L, Schwartz PJ (2019) Cardiac sympathetic denervation in channelopathies. Front Cardiovasc Med 6:27. https:\/\/doi.org\/10.3389\/fcvm.2019.00027","journal-title":"Front Cardiovasc Med"},{"key":"948_CR203","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacep.2021.09.002","volume":"8","author":"V Dusi","year":"2022","unstructured":"Dusi V, Pugliese L, De Ferrari GM, Odero A, Crotti L, Dagradi F, Castelletti S, Vicentini A, Rordorf R, Li C, Shkolnikova M, Spazzolini C, Schwartz PJ (2022) Left cardiac sympathetic denervation for long QT syndrome: 50 years\u2019 experience provides guidance for management. JACC Clin Electrophysiol 8:281\u2013294. https:\/\/doi.org\/10.1016\/j.jacep.2021.09.002","journal-title":"JACC Clin Electrophysiol"},{"key":"948_CR204","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/01.cir.84.2.503","volume":"84","author":"PJ Schwartz","year":"1991","unstructured":"Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U (1991) Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation 84:503\u2013511. https:\/\/doi.org\/10.1161\/01.cir.84.2.503","journal-title":"Circulation"},{"key":"948_CR205","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","volume":"109","author":"PJ Schwartz","year":"2004","unstructured":"Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D (2004) Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 109:1826\u20131833. https:\/\/doi.org\/10.1161\/01.CIR.0000125523.14403.1E","journal-title":"Circulation"},{"key":"948_CR206","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.hrthm.2009.06.033","volume":"6","author":"M Cerrone","year":"2009","unstructured":"Cerrone M, Napolitano C, Priori SG (2009) Catecholaminergic polymorphic ventricular tachycardia: a paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation. Heart Rhythm 6:1652\u20131659. https:\/\/doi.org\/10.1016\/j.hrthm.2009.06.033","journal-title":"Heart Rhythm"},{"key":"948_CR207","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1086\/324565","volume":"69","author":"H Lahat","year":"2001","unstructured":"Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M (2001) A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69:1378\u20131384. https:\/\/doi.org\/10.1086\/324565","journal-title":"Am J Hum Genet"},{"key":"948_CR208","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/01.cir.103.2.196","volume":"103","author":"SG Priori","year":"2001","unstructured":"Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA (2001) Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103:196\u2013200. https:\/\/doi.org\/10.1161\/01.cir.103.2.196","journal-title":"Circulation"},{"key":"948_CR209","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.hrthm.2006.12.016","volume":"4","author":"XH Wehrens","year":"2007","unstructured":"Wehrens XH (2007) The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms? Heart Rhythm 4:794\u2013797. https:\/\/doi.org\/10.1016\/j.hrthm.2006.12.016","journal-title":"Heart Rhythm"},{"key":"948_CR210","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/01.RES.0000192146.85173.4b","volume":"97","author":"D Jiang","year":"2005","unstructured":"Jiang D, Wang R, Xiao B, Kong H, Hunt DJ, Choi P, Zhang L, Chen SR (2005) Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 97:1173\u20131181. https:\/\/doi.org\/10.1161\/01.RES.0000192146.85173.4b","journal-title":"Circ Res"},{"key":"948_CR211","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1161\/01.CIR.0000132472.98675.EC","volume":"109","author":"SE Lehnart","year":"2004","unstructured":"Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR (2004) Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109:3208\u20133214. https:\/\/doi.org\/10.1161\/01.CIR.0000132472.98675.EC","journal-title":"Circulation"},{"key":"948_CR212","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/01.RES.0000235869.50747.e1","volume":"99","author":"N Liu","year":"2006","unstructured":"Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG (2006) Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 99:292\u2013298. https:\/\/doi.org\/10.1161\/01.RES.0000235869.50747.e1","journal-title":"Circ Res"},{"key":"948_CR213","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","volume":"131","author":"GM De Ferrari","year":"2015","unstructured":"De Ferrari GM, Dusi V, Spazzolini C, Bos JM, Abrams DJ, Berul CI, Crotti L, Davis AM, Eldar M, Kharlap M, Khoury A, Krahn AD, Leenhardt A, Moir CR, Odero A, Olde Nordkamp L, Paul T, Roses INF, Shkolnikova M, Till J, Wilde AA, Ackerman MJ, Schwartz PJ (2015) Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation 131:2185\u20132193. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015731","journal-title":"Circulation"},{"key":"948_CR214","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","volume":"119","author":"M Hayashi","year":"2009","unstructured":"Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A (2009) Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 119:2426\u20132434. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.829267","journal-title":"Circulation"},{"key":"948_CR215","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","volume":"14","author":"MJ Ackerman","year":"2017","unstructured":"Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, Triedman J, Van Hare GF, Gold MR (2017) Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent? Heart Rhythm 14:e41\u2013e44. https:\/\/doi.org\/10.1016\/j.hrthm.2016.09.012","journal-title":"Heart Rhythm"},{"key":"948_CR216","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","volume":"57","author":"C van der Werf","year":"2011","unstructured":"van der Werf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A, Shimizu W, Sumitomo N, Fish FA, Bhuiyan ZA, Willems AR, van der Veen MJ, Watanabe H, Laborderie J, Haissaguerre M, Knollmann BC, Wilde AA (2011) Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 57:2244\u20132254. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.026","journal-title":"J Am Coll Cardiol"},{"key":"948_CR217","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/CIRCRESAHA.111.247338","volume":"109","author":"N Liu","year":"2011","unstructured":"Liu N, Denegri M, Ruan Y, Avelino-Cruz JE, Perissi A, Negri S, Napolitano C, Coetzee WA, Boyden PA, Priori SG (2011) Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity. Circ Res 109:291\u2013295. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.247338","journal-title":"Circ Res"},{"key":"948_CR218","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nm.1942","volume":"15","author":"H Watanabe","year":"2009","unstructured":"Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE, Duff HJ, Roden DM, Wilde AA, Knollmann BC (2009) Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 15:380\u2013383. https:\/\/doi.org\/10.1038\/nm.1942","journal-title":"Nat Med"},{"key":"948_CR219","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","volume":"2","author":"PJ Kannankeril","year":"2017","unstructured":"Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, Batra AS, Kaufman ES, Fairbrother DL, Saarel EV, Etheridge SP, Kanter RJ, Carboni MP, Dzurik MV, Fountain D, Chen H, Ely EW, Roden DM, Knollmann BC (2017) Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial. JAMA Cardiol 2:759\u2013766. https:\/\/doi.org\/10.1001\/jamacardio.2017.1320","journal-title":"JAMA Cardiol"},{"key":"948_CR220","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.hrthm.2009.03.024","volume":"6","author":"CA Collura","year":"2009","unstructured":"Collura CA, Johnson JN, Moir C, Ackerman MJ (2009) Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm 6:752\u2013759. https:\/\/doi.org\/10.1016\/j.hrthm.2009.03.024","journal-title":"Heart Rhythm"},{"key":"948_CR221","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","volume":"358","author":"AA Wilde","year":"2008","unstructured":"Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ (2008) Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 358:2024\u20132029. https:\/\/doi.org\/10.1056\/NEJMoa0708006","journal-title":"N Engl J Med"},{"key":"948_CR222","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819\u2013823. https:\/\/doi.org\/10.1056\/NEJM198409273111303","journal-title":"N Engl J Med"},{"key":"948_CR223","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0002-9343(89)90228-3","volume":"86","author":"AS Maisel","year":"1989","unstructured":"Maisel AS, Scott NA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR (1989) Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med 86:43\u201348. https:\/\/doi.org\/10.1016\/0002-9343(89)90228-3","journal-title":"Am J Med"},{"key":"948_CR224","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","year":"1996","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043\u20131065","journal-title":"Circulation"},{"key":"948_CR225","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fpubh.2017.00258","volume":"5","author":"F Shaffer","year":"2017","unstructured":"Shaffer F, Ginsberg JP (2017) An overview of heart rate variability metrics and norms. Front Public Health 5:258. https:\/\/doi.org\/10.3389\/fpubh.2017.00258","journal-title":"Front Public Health"},{"key":"948_CR226","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/s0002-9149(97)89199-0","volume":"77","author":"L Fei","year":"1996","unstructured":"Fei L, Copie X, Malik M, Camm AJ (1996) Short- and long-term assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J Cardiol 77:681\u2013684. https:\/\/doi.org\/10.1016\/s0002-9149(97)89199-0","journal-title":"Am J Cardiol"},{"key":"948_CR227","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1542-474X.2005.10101.x","volume":"10","author":"RE Kleiger","year":"2005","unstructured":"Kleiger RE, Stein PK, Bigger JT Jr (2005) Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 10:88\u2013101. https:\/\/doi.org\/10.1111\/j.1542-474X.2005.10101.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"948_CR228","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/s0002-9149(97)00526-2","volume":"80","author":"W Jiang","year":"1997","unstructured":"Jiang W, Hathaway WR, McNulty S, Larsen RL, Hansley KL, Zhang Y, O\u2019Connor CM (1997) Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol 80:808\u2013811. https:\/\/doi.org\/10.1016\/s0002-9149(97)00526-2","journal-title":"Am J Cardiol"},{"key":"948_CR229","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/01.cir.98.15.1510","volume":"98","author":"J Nolan","year":"1998","unstructured":"Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98:1510\u20131516. https:\/\/doi.org\/10.1161\/01.cir.98.15.1510","journal-title":"Circulation"},{"key":"948_CR230","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fpsyg.2014.01040","volume":"5","author":"F Shaffer","year":"2014","unstructured":"Shaffer F, McCraty R, Zerr CL (2014) A healthy heart is not a metronome: an integrative review of the heart\u2019s anatomy and heart rate variability. Front Psychol 5:1040. https:\/\/doi.org\/10.3389\/fpsyg.2014.01040","journal-title":"Front Psychol"},{"key":"948_CR231","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1253\/circj.68.343","volume":"68","author":"M Hadase","year":"2004","unstructured":"Hadase M, Azuma A, Zen K, Asada S, Kawasaki T, Kamitani T, Kawasaki S, Sugihara H, Matsubara H (2004) Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure. Circ J 68:343\u2013347. https:\/\/doi.org\/10.1253\/circj.68.343","journal-title":"Circ J"},{"key":"948_CR232","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.cir.90.2.878","volume":"90","author":"H Tsuji","year":"1994","unstructured":"Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D (1994) Reduced heart rate variability and mortality risk in an elderly cohort the Framingham heart study. Circulation 90:878\u2013883. https:\/\/doi.org\/10.1161\/01.cir.90.2.878","journal-title":"Circulation"},{"key":"948_CR233","doi-asserted-by":"publisher","first-page":"041911","DOI":"10.1103\/PhysRevE.63.041911","volume":"63","author":"GC Kember","year":"2001","unstructured":"Kember GC, Fenton GA, Armour JA, Kalyaniwalla N (2001) Competition model for aperiodic stochastic resonance in a Fitzhugh-Nagumo model of cardiac sensory neurons. Phys Rev E Stat Nonlin Soft Matter Phys 63:041911. https:\/\/doi.org\/10.1103\/PhysRevE.63.041911","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"key":"948_CR234","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1103\/physreve.61.1816","volume":"61","author":"GC Kember","year":"2000","unstructured":"Kember GC, Fenton GA, Collier K, Armour JA (2000) Aperiodic stochastic resonance in a hysteretic population of cardiac neurons. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 61:1816\u20131824. https:\/\/doi.org\/10.1103\/physreve.61.1816","journal-title":"Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics"},{"key":"948_CR235","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1126\/science.6166045","volume":"213","author":"S Akselrod","year":"1981","unstructured":"Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213:220\u2013222. https:\/\/doi.org\/10.1126\/science.6166045","journal-title":"Science"},{"key":"948_CR236","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7453\/gahmj.2014.073","volume":"4","author":"R McCraty","year":"2015","unstructured":"McCraty R, Shaffer F (2015) Heart rate variability: new perspectives on physiological mechanisms, assessment of self-regulatory capacity, and health risk. Glob Adv Health Med 4:46\u201361. https:\/\/doi.org\/10.7453\/gahmj.2014.073","journal-title":"Glob Adv Health Med"},{"key":"948_CR237","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.biopsycho.2005.11.014","volume":"74","author":"P Grossman","year":"2007","unstructured":"Grossman P, Taylor EW (2007) Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biol Psychol 74:263\u2013285. https:\/\/doi.org\/10.1016\/j.biopsycho.2005.11.014","journal-title":"Biol Psychol"},{"key":"948_CR238","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fphys.2013.00026","volume":"4","author":"GE Billman","year":"2013","unstructured":"Billman GE (2013) The LF\/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 4:26. https:\/\/doi.org\/10.3389\/fphys.2013.00026","journal-title":"Front Physiol"},{"key":"948_CR239","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-444-53491-0.00008-0","volume":"117","author":"EA Wehrwein","year":"2013","unstructured":"Wehrwein EA, Joyner MJ (2013) Regulation of blood pressure by the arterial baroreflex and autonomic nervous system. Handb Clin Neurol 117:89\u2013102. https:\/\/doi.org\/10.1016\/B978-0-444-53491-0.00008-0","journal-title":"Handb Clin Neurol"},{"key":"948_CR240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb03662.x","volume":"940","author":"MW Chapleau","year":"2001","unstructured":"Chapleau MW, Li Z, Meyrelles SS, Ma X, Abboud FM (2001) Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci 940:1\u201319. https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03662.x","journal-title":"Ann N Y Acad Sci"},{"key":"948_CR241","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1542-474X.2008.00219.x","volume":"13","author":"MT La Rovere","year":"2008","unstructured":"La Rovere MT, Pinna GD, Raczak G (2008) Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol 13:191\u2013207. https:\/\/doi.org\/10.1111\/j.1542-474X.2008.00219.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"948_CR242","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s0140-6736(97)11144-8","volume":"351","author":"MT La Rovere","year":"1998","unstructured":"La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone And Reflexes After Myocardial Infarction) Investigators. Lancet 351:478\u2013484. https:\/\/doi.org\/10.1016\/s0140-6736(97)11144-8","journal-title":"Lancet"},{"key":"948_CR243","doi-asserted-by":"publisher","first-page":"R815","DOI":"10.1152\/ajpregu.00051.2002","volume":"283","author":"PA Lanfranchi","year":"2002","unstructured":"Lanfranchi PA, Somers VK (2002) Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol 283:R815-826. https:\/\/doi.org\/10.1152\/ajpregu.00051.2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"948_CR244","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1161\/01.cir.96.10.3450","volume":"96","author":"A Mortara","year":"1997","unstructured":"Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L (1997) Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation 96:3450\u20133458. https:\/\/doi.org\/10.1161\/01.cir.96.10.3450","journal-title":"Circulation"},{"key":"948_CR245","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2005.06.062","volume":"46","author":"GD Pinna","year":"2005","unstructured":"Pinna GD, Maestri R, Capomolla S, Febo O, Robbi E, Cobelli F, La Rovere MT (2005) Applicability and clinical relevance of the transfer function method in the assessment of baroreflex sensitivity in heart failure patients. J Am Coll Cardiol 46:1314\u20131321. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.062","journal-title":"J Am Coll Cardiol"},{"key":"948_CR246","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/S0140-6736(98)08428-1","volume":"353","author":"G Schmidt","year":"1999","unstructured":"Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schomig A (1999) Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 353:1390\u20131396. https:\/\/doi.org\/10.1016\/S0140-6736(98)08428-1","journal-title":"Lancet"},{"key":"948_CR247","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.hrthm.2009.11.004","volume":"7","author":"HV Huikuri","year":"2010","unstructured":"Huikuri HV, Exner DV, Kavanagh KM, Aggarwal SG, Mitchell LB, Messier MD, Becker D, Sheldon RS, Bloch Thomsen PE, Carisma IR (2010) Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events. Heart Rhythm 7:229\u2013235. https:\/\/doi.org\/10.1016\/j.hrthm.2009.11.004","journal-title":"Heart Rhythm"},{"key":"948_CR248","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1253\/circj.66.902","volume":"66","author":"J Koyama","year":"2002","unstructured":"Koyama J, Watanabe J, Yamada A, Koseki Y, Konno Y, Toda S, Shinozaki T, Miura M, Fukuchi M, Ninomiya M, Kagaya Y, Shirato K (2002) Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure. Circ J 66:902\u2013907. https:\/\/doi.org\/10.1253\/circj.66.902","journal-title":"Circ J"},{"key":"948_CR249","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/jm00368a008","volume":"27","author":"DM Wieland","year":"1984","unstructured":"Wieland DM, Mangner TJ, Inbasekaran MN, Brown LE, Wu JL (1984) Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J Med Chem 27:149\u2013155. https:\/\/doi.org\/10.1021\/jm00368a008","journal-title":"J Med Chem"},{"key":"948_CR250","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, Investigators A-H (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol 55:2212\u20132221. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.014","journal-title":"J Am Coll Cardiol"},{"key":"948_CR251","first-page":"471","volume":"33","author":"P Merlet","year":"1992","unstructured":"Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D et al (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33:471\u2013477","journal-title":"J Nucl Med"},{"key":"948_CR252","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/s1071-3581(98)90112-x","volume":"5","author":"T Nakata","year":"1998","unstructured":"Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, Tsuchihashi K, Shimamoto K (1998) Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 5:579\u2013590. https:\/\/doi.org\/10.1016\/s1071-3581(98)90112-x","journal-title":"J Nucl Cardiol"},{"key":"948_CR253","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/0735-1097(88)92608-3","volume":"12","author":"J Schofer","year":"1988","unstructured":"Schofer J, Spielmann R, Schuchert A, Weber K, Schluter M (1988) Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12:1252\u20131258. https:\/\/doi.org\/10.1016\/0735-1097(88)92608-3","journal-title":"J Am Coll Cardiol"},{"key":"948_CR254","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MNM.0000000000000608","volume":"38","author":"O Asghar","year":"2017","unstructured":"Asghar O, Arumugam P, Armstrong I, Ray S, Schmitt M, Malik RA (2017) Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods. Nucl Med Commun 38:44\u201350. https:\/\/doi.org\/10.1097\/MNM.0000000000000608","journal-title":"Nucl Med Commun"},{"key":"948_CR255","first-page":"1368","volume":"46","author":"AJ Luisi Jr","year":"2005","unstructured":"Luisi AJ Jr, Suzuki G, Dekemp R, Haka MS, Toorongian SA, Canty JM Jr, Fallavollita JA (2005) Regional 11C-hydroxyephedrine retention in hibernating myocardium: chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 46:1368\u20131374","journal-title":"J Nucl Med"},{"key":"948_CR256","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"EM Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, American College of C, American Heart A, Canadian Cardiovascular S (2004) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction\u2014executive summary. A report of the American college of cardiology\/American heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44:671\u2013719. https:\/\/doi.org\/10.1016\/j.jacc.2004.07.002","journal-title":"J Am Coll Cardiol"},{"key":"948_CR257","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:1757\u20131780. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.011","journal-title":"J Am Coll Cardiol"},{"key":"948_CR258","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS Investigators and Committees","year":"1999","unstructured":"CIBIS Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"948_CR259","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"948_CR260","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US carvedilol heart failure study group. N Engl J Med 334:1349\u20131355. https:\/\/doi.org\/10.1056\/NEJM199605233342101","journal-title":"N Engl J Med"},{"key":"948_CR261","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.coph.2012.12.002","volume":"13","author":"PM Vanhoutte","year":"2013","unstructured":"Vanhoutte PM, Gao Y (2013) Beta blockers, nitric oxide, and cardiovascular disease. Curr Opin Pharmacol 13:265\u2013273. https:\/\/doi.org\/10.1016\/j.coph.2012.12.002","journal-title":"Curr Opin Pharmacol"},{"key":"948_CR262","doi-asserted-by":"publisher","first-page":"21C","DOI":"10.1016\/0002-9149(90)90758-s","volume":"66","author":"P Jaillon","year":"1990","unstructured":"Jaillon P (1990) Relevance of intrinsic sympathomimetic activity for beta blockers. Am J Cardiol 66:21C-23C. https:\/\/doi.org\/10.1016\/0002-9149(90)90758-s","journal-title":"Am J Cardiol"},{"key":"948_CR263","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-g","volume":"46","author":"J McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163\u2013197. https:\/\/doi.org\/10.1016\/0163-7258(90)90092-g","journal-title":"Pharmacol Ther"},{"key":"948_CR264","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/cs0600343","volume":"60","author":"BG Zimmerman","year":"1981","unstructured":"Zimmerman BG (1981) Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci (Lond) 60:343\u2013348. https:\/\/doi.org\/10.1042\/cs0600343","journal-title":"Clin Sci (Lond)"},{"key":"948_CR265","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(25)28279-9","volume":"167","author":"MJ Peach","year":"1969","unstructured":"Peach MJ, Bumpus FM, Khairallah PA (1969) Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther 167:291\u2013299","journal-title":"J Pharmacol Exp Ther"},{"key":"948_CR266","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2017.06.016","volume":"125","author":"G Huber","year":"2017","unstructured":"Huber G, Schuster F, Raasch W (2017) Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases. Pharmacol Res 125:72\u201390. https:\/\/doi.org\/10.1016\/j.phrs.2017.06.016","journal-title":"Pharmacol Res"},{"key":"948_CR267","doi-asserted-by":"publisher","first-page":"E763","DOI":"10.1152\/ajpendo.1992.262.6.E763","volume":"262","author":"IA Reid","year":"1992","unstructured":"Reid IA (1992) Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262:E763-778. https:\/\/doi.org\/10.1152\/ajpendo.1992.262.6.E763","journal-title":"Am J Physiol"},{"key":"948_CR268","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00424-008-0627-x","volume":"458","author":"Z Shi","year":"2009","unstructured":"Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, Wang W, Zhu GQ (2009) Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Pflugers Arch 458:247\u2013257. https:\/\/doi.org\/10.1007\/s00424-008-0627-x","journal-title":"Pflugers Arch"},{"key":"948_CR269","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.autneu.2005.07.003","volume":"121","author":"HJ Wang","year":"2005","unstructured":"Wang HJ, Zhang F, Zhang Y, Gao XY, Wang W, Zhu GQ (2005) AT1 receptor in paraventricular nucleus mediates the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Auton Neurosci 121:56\u201363. https:\/\/doi.org\/10.1016\/j.autneu.2005.07.003","journal-title":"Auton Neurosci"},{"key":"948_CR270","doi-asserted-by":"publisher","first-page":"H15","DOI":"10.1152\/ajpheart.1999.277.1.H15","volume":"277","author":"R Ma","year":"1999","unstructured":"Ma R, Schultz HD, Wang W (1999) Chronic central infusion of ANG II potentiates cardiac sympathetic afferent reflex in dogs. Am J Physiol 277:H15-22. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.1.H15","journal-title":"Am J Physiol"},{"key":"948_CR271","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1016\/S0002-8703(03)00366-1","volume":"146","author":"E De Tommasi","year":"2003","unstructured":"De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV (2003) Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 146:E17. https:\/\/doi.org\/10.1016\/S0002-8703(03)00366-1","journal-title":"Am Heart J"},{"key":"948_CR272","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1161\/01.cir.96.4.1173","volume":"96","author":"G Grassi","year":"1997","unstructured":"Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G (1997) Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 96:1173\u20131179. https:\/\/doi.org\/10.1161\/01.cir.96.4.1173","journal-title":"Circulation"},{"key":"948_CR273","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00005344-200212000-00008","volume":"40","author":"M Hikosaka","year":"2002","unstructured":"Hikosaka M, Yuasa F, Yuyama R, Mimura J, Kawamura A, Motohiro M, Iwasaki M, Sugiura T, Iwasaka T (2002) Candesartan and arterial baroreflex sensitivity and sympathetic nerve activity in patients with mild heart failure. J Cardiovasc Pharmacol 40:875\u2013880. https:\/\/doi.org\/10.1097\/00005344-200212000-00008","journal-title":"J Cardiovasc Pharmacol"},{"key":"948_CR274","first-page":"1085","volume":"38","author":"Y Takeishi","year":"1997","unstructured":"Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H (1997) ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38:1085\u20131089","journal-title":"J Nucl Med"},{"key":"948_CR275","doi-asserted-by":"publisher","first-page":"e002744","DOI":"10.1161\/CIRCHEARTFAILURE.115.002744","volume":"9","author":"SD Solomon","year":"2016","unstructured":"Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan O, Dukat A, Lefkowitz MP, McMurray JJ (2016) Influence of ejection fraction on outcomes and efficacy of sacubitril\/valsartan (LCZ696) in heart failure with reduced ejection fraction: the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure (PARADIGM-HF) trial. Circ Heart Fail 9:e002744. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002744","journal-title":"Circ Heart Fail"},{"key":"948_CR276","doi-asserted-by":"publisher","first-page":"A13303","DOI":"10.1161\/circ.146.suppl_1.13303","volume":"146","author":"AA Boehmer","year":"2022","unstructured":"Boehmer AA, Schubert T, von Stuelpnagel L, Bauer A, Dobre B, Kaess BM, Ehrlich JR (2022) Abstract 13303: influence of ARNI on cardiac autonomic nervous system. Circulation 146:A13303","journal-title":"Circulation"},{"key":"948_CR277","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/HJH.0000000000001434","volume":"35","author":"VB Matthews","year":"2017","unstructured":"Matthews VB, Elliot RH, Rudnicka C, Hricova J, Herat L, Schlaich MP (2017) Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2. J Hypertens 35:2059\u20132068. https:\/\/doi.org\/10.1097\/HJH.0000000000001434","journal-title":"J Hypertens"},{"key":"948_CR278","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fendo.2018.00421","volume":"9","author":"N Wan","year":"2018","unstructured":"Wan N, Rahman A, Hitomi H, Nishiyama A (2018) The effects of sodium-glucose cotransporter 2 inhibitors on sympathetic nervous activity. Front Endocrinol (Lausanne) 9:421. https:\/\/doi.org\/10.3389\/fendo.2018.00421","journal-title":"Front Endocrinol (Lausanne)"},{"key":"948_CR279","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-020-01127-z","volume":"19","author":"W Shimizu","year":"2020","unstructured":"Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, Yodogawa K, Iwasaki YK, Yamamoto T, Takano H, Tsukada Y, Asai K, Miyamoto M, Miyauchi Y, Kodani E, Ishikawa M, Maruyama M, Ogano M, Tanabe J, investigators Et (2020) Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovasc Diabetol 19:148. https:\/\/doi.org\/10.1186\/s12933-020-01127-z","journal-title":"Cardiovasc Diabetol"},{"key":"948_CR280","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1540-8167.2008.01190.x","volume":"19","author":"YM Cha","year":"2008","unstructured":"Cha YM, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen WK, Asirvatham SJ, Kemp BJ, Hodge DO, Chen PS, Chareonthaitawee P (2008) Cardiac resynchronization therapy upregulates cardiac autonomic control. J Cardiovasc Electrophysiol 19:1045\u20131052. https:\/\/doi.org\/10.1111\/j.1540-8167.2008.01190.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"948_CR281","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10840-019-00623-x","volume":"56","author":"CK Alvarez","year":"2019","unstructured":"Alvarez CK, Cronin E, Baker WL, Kluger J (2019) Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol 56:229\u2013247. https:\/\/doi.org\/10.1007\/s10840-019-00623-x","journal-title":"J Interv Card Electrophysiol"},{"key":"948_CR282","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.jacc.2005.06.081","volume":"46","author":"C Fantoni","year":"2005","unstructured":"Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A (2005) Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 46:1875\u20131882. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.081","journal-title":"J Am Coll Cardiol"},{"key":"948_CR283","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijcard.2005.03.072","volume":"109","author":"S Sarzi Braga","year":"2006","unstructured":"Sarzi Braga S, La Rovere MT, Pedretti RF (2006) Baroreflex sensitivity normalization after cardiac resynchronization therapy. Int J Cardiol 109:118\u2013120. https:\/\/doi.org\/10.1016\/j.ijcard.2005.03.072","journal-title":"Int J Cardiol"},{"issue":"Suppl 1","key":"948_CR284","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1111\/j.1540-8159.2008.02260.x","volume":"32","author":"B Sredniawa","year":"2009","unstructured":"Sredniawa B, Lenarczyk R, Musialik-Lydka A, Kowalski O, Kowalczyk J, Cebula S, Sliwinska A, Szulik M, Kalarus Z (2009) Effects of cardiac resynchronization therapy on heart rate turbulence. Pacing Clin Electrophysiol 32(Suppl 1):S90-93. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.02260.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"948_CR285","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1152\/ajpheart.00644.2016","volume":"312","author":"T Irie","year":"2017","unstructured":"Irie T, Yamakawa K, Hamon D, Nakamura K, Shivkumar K, Vaseghi M (2017) Cardiac sympathetic innervation via middle cervical and stellate ganglia and antiarrhythmic mechanism of bilateral stellectomy. Am J Physiol Heart Circ Physiol 312:392\u2013405. https:\/\/doi.org\/10.1152\/ajpheart.00644.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"948_CR286","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.cir.62.6.1256","volume":"62","author":"PJ Schwartz","year":"1980","unstructured":"Schwartz PJ, Stone HL (1980) Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 62:1256\u20131265. https:\/\/doi.org\/10.1161\/01.cir.62.6.1256","journal-title":"Circulation"},{"key":"948_CR287","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1016\/j.jacc.2017.04.035","volume":"69","author":"M Vaseghi","year":"2017","unstructured":"Vaseghi M, Barwad P, Malavassi Corrales FJ, Tandri H, Mathuria N, Shah R, Sorg JM, Gima J, Mandal K, Saenz Morales LC, Lokhandwala Y, Shivkumar K (2017) Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol 69:3070\u20133080. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.035","journal-title":"J Am Coll Cardiol"},{"key":"948_CR288","doi-asserted-by":"publisher","first-page":"e018371","DOI":"10.1161\/JAHA.120.018371","volume":"10","author":"V Dusi","year":"2021","unstructured":"Dusi V, Gornbein J, Do DH, Sorg JM, Khakpour H, Krokhaleva Y, Ajijola OA, Macias C, Bradfield JS, Buch E, Fujimura OA, Boyle NG, Yanagawa J, Lee JM, Shivkumar K, Vaseghi M (2021) Arrhythmic risk profile and outcomes of patients undergoing cardiac sympathetic denervation for recurrent monomorphic ventricular tachycardia after ablation. J Am Heart Assoc 10:e018371. https:\/\/doi.org\/10.1161\/JAHA.120.018371","journal-title":"J Am Heart Assoc"},{"key":"948_CR289","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/eurjhf\/hfs132","volume":"14","author":"GE Conceicao-Souza","year":"2012","unstructured":"Conceicao-Souza GE, Pego-Fernandes PM, Cruz F, Guimaraes GV, Bacal F, Vieira ML, Grupi CJ, Giorgi MC, Consolim-Colombo FM, Negrao CE, Rondon MU, Moreira LF, Bocchi EA (2012) Left cardiac sympathetic denervation for treatment of symptomatic systolic heart failure patients: a pilot study. Eur J Heart Fail 14:1366\u20131373. https:\/\/doi.org\/10.1093\/eurjhf\/hfs132","journal-title":"Eur J Heart Fail"},{"key":"948_CR290","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hrthm.2013.11.028","volume":"11","author":"M Vaseghi","year":"2014","unstructured":"Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, Mahajan A, Shivkumar K (2014) Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm 11:360\u2013366. https:\/\/doi.org\/10.1016\/j.hrthm.2013.11.028","journal-title":"Heart Rhythm"},{"key":"948_CR291","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCEP.115.003159","volume":"8","author":"KE Waddell-Smith","year":"2015","unstructured":"Waddell-Smith KE, Ertresvaag KN, Li J, Chaudhuri K, Crawford JR, Hamill JK, Haydock D, Skinner JR, Cardiac Inherited Disease Group New Z (2015) Physical and psychological consequences of left cardiac sympathetic denervation in long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol 8:1151\u20131158. https:\/\/doi.org\/10.1161\/CIRCEP.115.003159","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"948_CR292","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1111\/jce.14233","volume":"30","author":"YM Cha","year":"2019","unstructured":"Cha YM, Li X, Yang M, Han J, Wu G, Kapa SC, McLeod CJ, Noseworthy PA, Mulpuru SK, Asirvatham SJ, Brady PA, Rho RH, Friedman PA, Lee HC, Tian Y, Zhou S, Munger TM, Ackerman MJ, Shen WK (2019) Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia. J Cardiovasc Electrophysiol 30:2920\u20132928. https:\/\/doi.org\/10.1111\/jce.14233","journal-title":"J Cardiovasc Electrophysiol"},{"key":"948_CR293","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jacep.2020.09.032","volume":"7","author":"S Sanghai","year":"2021","unstructured":"Sanghai S, Abbott NJ, Dewland TA, Henrikson CA, Elman MR, Wollenberg M, Ivie R, Gonzalez-Sotomayor J, Nazer B (2021) Stellate Ganglion blockade with continuous infusion versus single injection for treatment of ventricular arrhythmia storm. JACC Clin Electrophysiol 7:452\u2013460. https:\/\/doi.org\/10.1016\/j.jacep.2020.09.032","journal-title":"JACC Clin Electrophysiol"},{"key":"948_CR294","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jacep.2019.12.017","volume":"6","author":"M Fudim","year":"2020","unstructured":"Fudim M, Qadri YJ, Waldron NH, Boortz-Marx RL, Ganesh A, Patel CB, Podgoreanu MV, Sun AY, Milano CA, Tong BC, Harpole DH Jr, Mathew JP, Piccini JP (2020) Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias. JACC Clin Electrophysiol 6:562\u2013571. https:\/\/doi.org\/10.1016\/j.jacep.2019.12.017","journal-title":"JACC Clin Electrophysiol"},{"key":"948_CR295","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1053\/j.jvca.2019.12.015","volume":"34","author":"ED Wittwer","year":"2020","unstructured":"Wittwer ED, Radosevich MA, Ritter M, Cha YM (2020) Stellate ganglion blockade for refractory ventricular arrhythmias: implications of ultrasound-guided technique and review of the evidence. J Cardiothorac Vasc Anesth 34:2245\u20132252. https:\/\/doi.org\/10.1053\/j.jvca.2019.12.015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"948_CR296","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4103\/aca.ACA_98_18","volume":"22","author":"S Basantwani","year":"2019","unstructured":"Basantwani S, Shinde SR, Tendolkar B (2019) Management of ventricular storm with thoracic epidural anesthesia. Ann Card Anaesth 22:439\u2013441. https:\/\/doi.org\/10.4103\/aca.ACA_98_18","journal-title":"Ann Card Anaesth"},{"key":"948_CR297","doi-asserted-by":"publisher","first-page":"e007080","DOI":"10.1161\/JAHA.117.007080","volume":"6","author":"DH Do","year":"2017","unstructured":"Do DH, Bradfield J, Ajijola OA, Vaseghi M, Le J, Rahman S, Mahajan A, Nogami A, Boyle NG, Shivkumar K (2017) Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc 6:e007080. https:\/\/doi.org\/10.1161\/JAHA.117.007080","journal-title":"J Am Heart Assoc"},{"key":"948_CR298","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/ALN.0000000000001613","volume":"126","author":"K Howard-Quijano","year":"2017","unstructured":"Howard-Quijano K, Takamiya T, Dale EA, Yamakawa K, Zhou W, Buckley U, Mahajan A (2017) Effect of thoracic epidural anesthesia on ventricular excitability in a porcine model. Anesthesiology 126:1096\u20131106. https:\/\/doi.org\/10.1097\/ALN.0000000000001613","journal-title":"Anesthesiology"},{"key":"948_CR299","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.109.929703","volume":"121","author":"T Bourke","year":"2010","unstructured":"Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, Swapna N, Boyle NG, Mahajan A, Narasimhan C, Lokhandwala Y, Shivkumar K (2010) Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 121:2255\u20132262. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.929703","journal-title":"Circulation"},{"key":"948_CR300","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/hr.2011.115","volume":"34","author":"Y Fujisawa","year":"2011","unstructured":"Fujisawa Y, Nagai Y, Lei B, Nakano D, Fukui T, Hitomi H, Mori H, Masaki T, Nishiyama A (2011) Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats. Hypertens Res 34:1228\u20131232. https:\/\/doi.org\/10.1038\/hr.2011.115","journal-title":"Hypertens Res"},{"key":"948_CR301","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12265-021-10149-1","volume":"15","author":"H Zhou","year":"2022","unstructured":"Zhou H, Li Y, Xu Y, Liu H, Lai Y, Tan K, Liu X, Ou Z, Chen W, Du H, Liu Z, Yin Y (2022) Mapping renal innervations by renal nerve stimulation and characterizations of blood pressure response patterns. J Cardiovasc Transl Res 15:29\u201337. https:\/\/doi.org\/10.1007\/s12265-021-10149-1","journal-title":"J Cardiovasc Transl Res"},{"key":"948_CR302","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","volume":"57","author":"HTNI Symplicity","year":"2011","unstructured":"Symplicity HTNI (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911\u2013917. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.163014","journal-title":"Hypertension"},{"key":"948_CR303","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"HTNI Symplicity","year":"2010","unstructured":"Symplicity HTNI, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903\u20131909. https:\/\/doi.org\/10.1016\/S0140-6736(10)62039-9","journal-title":"Lancet"},{"key":"948_CR304","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O\u2019Neill WW, D\u2019Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, SYMPLICITY HTN-3 Investigators (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:1393\u20131401. https:\/\/doi.org\/10.1056\/NEJMoa1402670","journal-title":"N Engl J Med"},{"key":"948_CR305","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","volume":"395","author":"M Bohm","year":"2020","unstructured":"Bohm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D\u2019Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR, Investigators SH-OMP (2020) Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet 395:1444\u20131451. https:\/\/doi.org\/10.1016\/S0140-6736(20)30554-7","journal-title":"Lancet"},{"key":"948_CR306","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","volume":"391","author":"DE Kandzari","year":"2018","unstructured":"Kandzari DE, Bohm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K, Investigators SH-OMT (2018) Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 391:2346\u20132355. https:\/\/doi.org\/10.1016\/S0140-6736(18)30951-6","journal-title":"Lancet"},{"key":"948_CR307","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/S0140-6736(17)32281-X","volume":"390","author":"RR Townsend","year":"2017","unstructured":"Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Bohm M (2017) Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 390:2160\u20132170. https:\/\/doi.org\/10.1016\/S0140-6736(17)32281-X","journal-title":"Lancet"},{"key":"948_CR308","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/HYPERTENSIONAHA.116.07492","volume":"68","author":"MR de Jong","year":"2016","unstructured":"de Jong MR, Adiyaman A, Gal P, Smit JJ, Delnoy PP, Heeg JE, van Hasselt BA, Lau EO, Persu A, Staessen JA, Ramdat Misier AR, Steinberg JS, Elvan A (2016) Renal nerve stimulation-induced blood pressure changes predict ambulatory blood pressure response after renal denervation. Hypertension 68:707\u2013714. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07492","journal-title":"Hypertension"},{"key":"948_CR309","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/08037051.2021.1982376","volume":"30","author":"AF Hoogerwaard","year":"2021","unstructured":"Hoogerwaard AF, Adiyaman A, de Jong MR, Smit JJ, Heeg JE, van Hasselt B, Elvan A (2021) Renal nerve stimulation: complete versus incomplete renal sympathetic denervation. Blood Press 30:376\u2013385. https:\/\/doi.org\/10.1080\/08037051.2021.1982376","journal-title":"Blood Press"},{"key":"948_CR310","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jacep.2020.07.019","volume":"7","author":"J Hawson","year":"2021","unstructured":"Hawson J, Harmer JA, Cowan M, Virk S, Campbell T, Bennett RG, Anderson RD, Kalman J, Lee G, Kumar S (2021) Renal denervation for the management of refractory ventricular arrhythmias: a systematic review. JACC Clin Electrophysiol 7:100\u2013108. https:\/\/doi.org\/10.1016\/j.jacep.2020.07.019","journal-title":"JACC Clin Electrophysiol"},{"key":"948_CR311","doi-asserted-by":"publisher","first-page":"e009938","DOI":"10.1161\/JAHA.118.009938","volume":"7","author":"WH Zhang","year":"2018","unstructured":"Zhang WH, Zhou QN, Lu YM, Li YD, Zhang L, Zhang JH, Xing Q, Lv WK, Cheng XC, Zhang GG, Wang XS, Gu Q, Lou X, Guli B, Tang BP, Zhou XH (2018) Renal denervation reduced ventricular arrhythmia after myocardial infarction by inhibiting sympathetic activity and remodeling. J Am Heart Assoc 7:e009938. https:\/\/doi.org\/10.1161\/JAHA.118.009938","journal-title":"J Am Heart Assoc"},{"key":"948_CR312","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.110.955013","volume":"4","author":"HN Sabbah","year":"2011","unstructured":"Sabbah HN, Gupta RC, Imai M, Irwin ED, Rastogi S, Rossing MA, Kieval RS (2011) Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail 4:65\u201370. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.955013","journal-title":"Circ Heart Fail"},{"key":"948_CR313","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.107.095216","volume":"50","author":"IH Zucker","year":"2007","unstructured":"Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA (2007) Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension 50:904\u2013910. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.095216","journal-title":"Hypertension"},{"key":"948_CR314","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Muller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC (2015) Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction. JACC Heart Fail 3:487\u2013496. https:\/\/doi.org\/10.1016\/j.jchf.2015.02.006","journal-title":"JACC Heart Fail"},{"key":"948_CR315","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","volume":"58","author":"JD Bisognano","year":"2011","unstructured":"Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA (2011) Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 58:765\u2013773. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.008","journal-title":"J Am Coll Cardiol"},{"key":"948_CR316","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1097\/HJH.0000000000000603","volume":"33","author":"E Gronda","year":"2015","unstructured":"Gronda E, Seravalle G, Trevano FQ, Costantino G, Casini A, Alsheraei A, Lovett EG, Vanoli E, Mancia G, Grassi G (2015) Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction. J Hypertens 33:1704\u20131708. https:\/\/doi.org\/10.1097\/HJH.0000000000000603","journal-title":"J Hypertens"},{"key":"948_CR317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","volume":"76","author":"MR Zile","year":"2020","unstructured":"Zile MR, Lindenfeld J, Weaver FA, Zannad F, Galle E, Rogers T, Abraham WT (2020) Baroreflex activation therapy in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol 76:1\u201313. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.015","journal-title":"J Am Coll Cardiol"},{"key":"948_CR318","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/HYPERTENSIONAHA.114.04492","volume":"65","author":"PW de Leeuw","year":"2015","unstructured":"de Leeuw PW, Alnima T, Lovett E, Sica D, Bisognano J, Haller H, Kroon AA (2015) Bilateral or unilateral stimulation for baroreflex activation therapy. Hypertension 65:187\u2013192. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04492","journal-title":"Hypertension"},{"key":"948_CR319","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/eurjhf\/hft118","volume":"15","author":"JJ Hamann","year":"2013","unstructured":"Hamann JJ, Ruble SB, Stolen C, Wang M, Gupta RC, Rastogi S, Sabbah HN (2013) Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure. Eur J Heart Fail 15:1319\u20131326. https:\/\/doi.org\/10.1093\/eurjhf\/hft118","journal-title":"Eur J Heart Fail"},{"key":"948_CR320","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","volume":"109","author":"M Li","year":"2004","unstructured":"Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109:120\u2013124. https:\/\/doi.org\/10.1161\/01.CIR.0000105721.71640.DA","journal-title":"Circulation"},{"key":"948_CR321","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10741-010-9209-z","volume":"16","author":"HN Sabbah","year":"2011","unstructured":"Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC (2011) Vagus nerve stimulation in experimental heart failure. Heart Fail Rev 16:171\u2013178. https:\/\/doi.org\/10.1007\/s10741-010-9209-z","journal-title":"Heart Fail Rev"},{"key":"948_CR322","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cardfail.2014.08.009","volume":"20","author":"RK Premchand","year":"2014","unstructured":"Premchand RK, Sharma K, Mittal S, Monteiro R, Dixit S, Libbus I, DiCarlo LA, Ardell JL, Rector TS, Amurthur B, KenKnight BH, Anand IS (2014) Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial. J Card Fail 20:808\u2013816. https:\/\/doi.org\/10.1016\/j.cardfail.2014.08.009","journal-title":"J Card Fail"},{"key":"948_CR323","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.hrthm.2009.08.012","volume":"6","author":"PJ Schwartz","year":"2009","unstructured":"Schwartz PJ, De Ferrari GM (2009) Vagal stimulation for heart failure: background and first in-man study. Heart Rhythm 6:S76-81. https:\/\/doi.org\/10.1016\/j.hrthm.2009.08.012","journal-title":"Heart Rhythm"},{"key":"948_CR324","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","volume":"68","author":"MR Gold","year":"2016","unstructured":"Gold MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, Kubo SH, Lieberman RA, Milasinovic G, Berman BJ, Djordjevic S, Neelagaru S, Schwartz PJ, Starling RC, Mann DL (2016) Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial. J Am Coll Cardiol 68:149\u2013158. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.525","journal-title":"J Am Coll Cardiol"},{"key":"948_CR325","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","volume":"36","author":"F Zannad","year":"2015","unstructured":"Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, Klein H, Stolen C, Meyer S, Stein KM, Ramuzat A, Schubert B, Daum D, Neuzil P, Botman C, Castel MA, D\u2019Onofrio A, Solomon SD, Wold N, Ruble SB (2015) Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J 36:425\u2013433. https:\/\/doi.org\/10.1093\/eurheartj\/ehu345","journal-title":"Eur Heart J"},{"key":"948_CR326","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ehf2.12592","volume":"7","author":"IS Anand","year":"2020","unstructured":"Anand IS, Konstam MA, Klein HU, Mann DL, Ardell JL, Gregory DD, Massaro JM, Libbus I, DiCarlo LA, Udelson JJE, Butler J, Parker JD, Teerlink JR (2020) Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. ESC Heart Fail 7:75\u201383. https:\/\/doi.org\/10.1002\/ehf2.12592","journal-title":"ESC Heart Fail"},{"key":"948_CR327","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1113\/JP274678","volume":"595","author":"JL Ardell","year":"2017","unstructured":"Ardell JL, Nier H, Hammer M, Southerland EM, Ardell CL, Beaumont E, KenKnight BH, Armour JA (2017) Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control. J Physiol 595:6887\u20136903. https:\/\/doi.org\/10.1113\/JP274678","journal-title":"J Physiol"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-023-00948-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-023-00948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:57:22Z","timestamp":1744214242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-023-00948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":327,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s10286-023-00948-8","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}